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Abstract The present overview is intended to point the
readers’ attention to the important subject of calcium
orthophosphates (CaPO4). This type of materials is of the
special significance for the human beings because they
represent the inorganic part of major normal (bones, teeth
and antlers) and pathological (i.e., those appearing due to
various diseases) calcified tissues of mammals. For exam-
ple, atherosclerosis results in blood vessel blockage caused
by a solid composite of cholesterol with CaPO4, while
dental caries and osteoporosis mean a partial decalcifica-
tion of teeth and bones, respectively, that results in
replacement of a less soluble and harder biological apatite
by more soluble and softer calcium hydrogenorthophos-
phates. Therefore, the processes of both normal and
pathological calcifications are just an in vivo crystallization
of CaPO4. Similarly, dental caries and osteoporosis might
be considered as in vivo dissolution of CaPO4. In addition,
natural CaPO4 are the major source of phosphorus, which
is used to produce agricultural fertilizers, detergents and
various phosphorus-containing chemicals. Thus, there is a
great significance of CaPO4 for the humankind and, in this
paper, an overview on the current knowledge on this sub-
ject is provided.
Keywords Calcium orthophosphates  Hydroxyapatite 
Fluorapatite  Bones  Teeth  Antlers  Calcification 
Crystallization  Biomimetics
Introduction
Due to the abundance in nature (as phosphate ores) and
presence in living organisms (as bones, teeth, deer antlers
and the majority of various pathological calcifications),
calcium phosphates are the inorganic compounds of a special
interest for human being. They were discovered in 1769 and
have been investigated since then (Dorozhkin 2012a, 2013a).
According to the databases of scientific literature (Web of
knowledge, Scopus, Medline, etc.), the total amount of
currently available publications on the subject exceeds
40,000 with the annual increase for, at least, 2000 papers.
This is a clear confirmation of the importance.
Briefly, by definition, all known calcium phosphates
consist of three major chemical elements: calcium (oxi-
dation state ?2), phosphorus (oxidation state ?5) and
oxygen (reduction state -2), as a part of the phosphate
anions. These three chemical elements are present in
abundance on the surface of our planet: oxygen is the most
widespread chemical element of the earth’s surface (*47
mass %), calcium occupies the fifth place (*3.3–3.4
mass %) and phosphorus (*0.08–0.12 mass%) is among
the first 20 of the chemical elements most widespread on
our planet (Lide 2005). In addition, the chemical compo-
sition of many calcium phosphates includes hydrogen, as
an acidic orthophosphate anion (for example, HPO4
2- or
H2PO4
-), hydroxide [for example, Ca10(PO4)6(OH)2] and/
or incorporated water (for example, CaHPO42H2O).
Regarding their chemical composition, diverse combina-
tions of CaO and P2O5 oxides (both in the presence of
water and without it) provide a large variety of calcium
phosphates, which are differentiated by the type of the




4-) and poly- ((PO3)n
n-) phosphates are known.
Furthermore, in the case of multi-charged anions (valid for
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orthophosphates and pyrophosphates), calcium phosphates
are also differentiated by the number of hydrogen ions
substituted by calcium ones. The examples comprise
mono- (Ca(H2PO4)2), di- (CaHPO4), tri- (Ca3(PO4)2) and
tetra- (Ca2P2O7) calcium phosphates (LeGeros 1991;
Elliott 1994; Amjad 1997). However, to narrow the subject,
calcium orthophosphates (abbreviated as CaPO4) will be
considered and discussed only. Their names, standard
abbreviations, chemical formulae and solubility values are
listed in Table 1 (Dorozhkin 2011, b). Since all of them
belong to CaPO4, strictly speaking, all abbreviations in
Table 1 are incorrect; however, they have been extensively
used in literature for decades and, to avoid confusion, there
is no need to modify them.
In general, the atomic arrangement of all CaPO4 is built
up around a network of orthophosphate (PO4) groups,
which stabilize the entire structure. Therefore, the majority
of CaPO4 are sparingly soluble in water (Table 1); how-
ever, all of them are easily soluble in acids but insoluble in
alkaline solutions. In addition, all chemically pure CaPO4
are colorless transparent crystals of moderate hardness but,
as powders, they are of white color. Nevertheless, natural
minerals of CaPO4 are always colored due the presence of
impurities and dopants, such as ions of Fe, Mn and rare
earth elements (Cantelar et al. 2001; Ribeiro et al. 2005).
Biologically formed CaPO4 are the major component of all
mammalian calcified tissues (Lowenstam and Weiner
1989), while the geologically formed ones are the major
raw material to produce phosphorus-containing agricultural
fertilizers, chemicals and detergents (McConnell 1973;
Becker 1989; Rakovan and Pasteris 2015).
Geological and biological occurrences
Geologically, natural CaPO4 are found in different regions
mostly as deposits of apatites, mainly as ion-substituted FA
(igneous rocks), and phosphorites (sedimentary rocks)








pH stability range in
aqueous solutions at
25 C
0.5 Monocalcium phosphate monohydrate
(MCPM)
Ca(H2PO4)2H2O 1.14 *18 0.0–2.0




1.0 Dicalcium phosphate dihydrate (DCPD),
mineral brushite
CaHPO42H2O 6.59 *0.088 2.0–6.0
1.0 Dicalcium phosphate anhydrous (DCPA
or DCP), mineral monetite
CaHPO4 6.90 *0.048
c
1.33 Octacalcium phosphate (OCP) Ca8(HPO4)2(PO4)45H2O 96.6 *0.0081 5.5–7.0
1.5 a-Tricalcium phosphate (a-TCP) a-Ca3(PO4)2 25.5 *0.0025
a
1.5 b-Tricalcium phosphate (b-TCP) b-Ca3(PO4)2 28.9 *0.0005
a
1.2–2.2 Amorphous calcium phosphates (ACP) CaxHy(PO4)znH2O,
n = 3–4.5; 15–20 % H2O
b b *5–12d
1.5–1.67 Calcium-deficient hydroxyapatite (CDHA
or Ca-def HA)e
C-x(HPO4)x(PO4)6-x
(OH)2-x (0\ x\ 1)
*85 *0.0094 6.5–9.5
1.67 Hydroxyapatite (HA, HAp or OHAp) Ca10(PO4)6(OH)2 116.8 *0.0003 9.5–12
1.67 Fluorapatite (FA or FAp) Ca10(PO4)6F2 120.0 *0.0002 7–12








a These compounds cannot be precipitated from aqueous solutions
b Cannot be measured precisely. However, the following values were found: 25.7 ± 0.1 (pH = 7.40), 29.9 ± 0.1 (pH = 6.00), 32.7 ± 0.1
(pH = 5.28) (Ohura et al. 1996). The comparative extent of dissolution in acidic buffer is: ACP  a-TCP  b-TCP[CDHA  HA[FA
(Daculsi et al. 1997)
c Stable at temperatures above 100 C
d Always metastable
e Occasionally, it is called ‘‘precipitated HA (PHA)’’
f Existence of OA remains questionable
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(Becker 1989; Rakovan and Pasteris 2015; Cook et al.
2005; Dumoulin et al. 2011). In addition, natural ion-sub-
stituted CDHA was also found (Mitchell et al. 1943) but it
is a very rare mineral. Some types of sedimentary rocks can
be formed by weathering of igneous rocks into smaller
particles (Zhang et al. 2010a). Other types of sedimentary
rocks can be composed of minerals precipitated from the
dissolution products of igneous rocks or minerals produced
by biomineralization (Fig. 1; Omelon and Grynpas 2008).
Thus, due to a sedimentary origin, both a general appear-
ance and a chemical composition of natural phosphorites
vary a lot (Jarvis 1994; Glenn 1994). It is a common
practice to consider francolite (or carbonate-hydroxyfluo-
rapatite regarded as its synonym) as the basic phosphorite
mineral (Cook et al. 2005; McClellan 1980; Mcarthur
1985; Zanin 2004; Lapin and Lyagushkin 2014). Accord-
ing to Henry (1850), the name francolite was given by Mr.
Brooke and Mr. Nuttall to a mineral from Wheal Franco,
Tavistock, Devon, some years prior to 1850. A cryp-
tocrystalline (almost amorphous) variety of francolite
(partly of a biological origin) is called collophane (syn-
onyms: collophanit, collophanita, collophanite, grodnolite,
kollophan), named in 1870 by Karl Ludwig Fridolin von
Sandberger from the Greek roots jokka (=glue) and
uaimerhai (to appear) referring to the appearance of the
mineral (Rogers 1922; Cao et al. 2013; http://www.mindat.
org/min-10072.html). Francolite is found in natural phos-
phorites predominantly as fossil bones and phosphatized
microbial pseudomorphs: phosphatic crusts of chasmolithic
biofilms (or microstromatolites) and globular clusters with
intra-particular porosities (Elorza et al. 1999; Hubert et al.
2005; Xiao et al. 1998, 2000). Natural phosphorites
(therefore, francolite and collophane as well) occur in
various forms, such as nodules, crystals or masses. Occa-
sionally, other types of natural CaPO4 are found as min-
erals, for example clinohydroxylapatite (Chakhmouradian
and Medici 2006), staffelite (synonyms: staffelit, staffelita)
belonging to carbonate-rich fluorapatites (chemical for-
mula: Ca5[(F,O)(PO4,CO3)3]) (Mason et al. 2009; http://
www.mindat.org/gallery.php?min=9293) and DCPD
(Klein 1901; Kaflak-Hachulska et al. 2000). Furthermore,
CaPO4 were found in meteoric stones (Merrill 1917;
McCubbin and Nekvasil 2008; McCubbin et al. 2014). The
world deposits of natural CaPO4 are estimated to exceed
150 billion tons; from which approximately 85 % belong to
phosphorites and the remaining *15 % belong to apatites
(Cook et al. 2005).
As minor constituents (\*5 %), natural CaPO4 (both
apatites and phosphorites) occur in many geological envi-
ronments. Concentrations sufficient for economic use
([15 %) are also available. Namely, the largest world
deposits of natural apatites are located in Russia [the
Khibiny and Kovdor massifs, Kola peninsula (Lapin and
Lyagushkin 2014; Tyrrell 1938; Kogarko 1999)], Brazil
and Zambia, while the largest world deposits of natural
phosphorites are located in Morocco, Russia, Kazakhstan,
USA (Florida, Tennessee), China and Australia (McCon-
nell 1973; Becker 1989; Rakovan and Pasteris 2015; Cook
et al. 2005). In addition, they are found at seabed and ocean
floor (Baturin 2012). There is an opinion, that the marine
phosphorites could be formed due to microbial activity
(Schulz and Schulz 2005; Crosby and Bailey 2012). The
majority of natural CaPO4 occur as small polycrystalline
structures (spherulitic clusters). Larger crystals are rare
(Ford 1917). They usually have the crystal structure of
apatites (hexagonal system, space group P63/m). Giant
crystals including ‘‘a solid but irregular mass of green
crystalline apatite, 15 feet long and 9 feet wide’’ (Hogarth
1974) and a single euhedral crystal from the Aetna mine
measuring 2.1 9 1.2 m with an estimated weight of 6 tons
(van Velthuizen 1992) were found. None of them is a pure
compound; they always contain dopants of other elements.





ions of calcium might be partially replaced by Sr, Ba, Mg,
Mn, K, Na, Fe, while ions of hydroxide, chloride, bromide,
carbonate and oxide may to a certain extent substitute
fluoride in the crystal lattice of natural apatites (Pan and
Fleet 2002). Furthermore, organic compounds have been
found in natural apatites (Gilinskaya 2010; Gilinskaya and
Zanin 2012). In principle, the crystal structure of apatites
can incorporate half the Periodic Chart of the elements in
almost any valence state into its atomic arrangement.
Namely, substituents such as the first row transition ele-
ments and the lanthanides (they act as activators and
chromophores) impart colors and can lead to luminescence.
Furthermore, crystal imperfections, such as site vacancies,
vacancies with trapped electrons and point defect clusters,
can likewise influence both color and luminescence
(Rakovan and Pasteris 2015). The substitutions in apatites
Fig. 1 A simplified schematic of the phosphorus cycle from apatitic
igneous rock to phosphorite sedimentary rock through chemical or
physical weathering. Life forms accumulate soluble phosphorus
species and can produce apatite through biomineralization. Reprinted
from Ref. (Omelon and Grynpas 2008) with permission
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are usually in trace concentrations; however, for certain
dopants (e.g., F- and OH-) large concentrations and even
complete solid solutions exist. To make things even more
complicated, some ions in the crystal structure may be
missing, leaving the crystallographic defects, which leads
to formation of non-stoichiometric compounds, such as
CDHA. Due to their affinity for chromophoric substituents
and propensity for other defects, natural apatites are found
in just about all colors of the rainbow. Ease of atomic
substitution for apatite leaves this mineral open to a wide
array of compositions. This might be related to the fact that
the apatite structure type displays porous properties (White
et al. 2005). In medicine, this property might be used as an
antidote for heavy metal intoxication (Sa´nchez-Salcedo
et al. 2010). Figure 2 shows some examples of natural FA.
Manufacturing of elementary phosphorus (white and
red) (Jacob and Reynolds 1928; Emsley 2001), phospho-
ric acids (Becker 1989; Dorozhkin 1996, 1997, 1998;
Gilmour 2014), various P-containing chemicals, agricul-
tural fertilizers [namely, superphosphate (Copson et al.
1936; Newton and Copson 1936; Rossete et al. 2008),
ammonium orthophosphates (Magda et al. 2008)] and
detergents [principally sodium tripolyphosphate (Ki-
jkowska et al. 2007)] are the major industrial applications
of natural CaPO4. The annual consumption of a phosphate
rock has approached *150 million tons and about 95 %
of this production is utilized in the fertilizer industry
(Abouzeid 2007, 2008). However, the significance of
CaPO4 to the society is by no means limited to their role
as a source of phosphorus; all currently available appli-
cations have been summarized in Table 2 (Rakovan and
Pasteris 2015).
In biological systems, many organisms, ranging from
bacteria and isolated cells to invertebrates and vertebrates,
synthesize CaPO4 (Omelon and Grynpas 2008). Formation
of solid CaPO4 in primitive organisms is believed to enable
the storage and regulation of essential elements such as
calcium, phosphorus and, possibly, magnesium. The mor-
phology of precipitates in these organisms (small intra-
cellular nodules of ACP often located in mitochondria)
complies with the necessities for rapid mobilization and
intracellular control of the concentration of these elements
(Rey et al. 2006). In vertebrates CaPO4 occur as the prin-
cipal inorganic constituent of normal (bones, teeth, fish
enameloid, deer antlers and some species of shells) and
pathological (dental and urinary calculus and stones,
atherosclerotic lesions, etc.) calcifications (Lowenstam and
Weiner 1989; O’Neill 2007; LeGeros 2001; Wopenka and
Pasteris 2005; Pasteris et al. 2008; Sun and Hanley 2007).
In addition, they are found in ganoid fish scales (in alligator
gar and Senegal bichir), turtle shells, as well as in armadillo
and alligator osteoderms (Currey 2010). In minute quan-
tities CaPO4 exist in the brain (brain sand), without sig-
nificantly affecting its function (Bocchi and Valdre 1993).
Therefore, the expression ‘‘having sand in the head’’ is not
without a reason. Except for small portions of the inner ear,
all hard tissues of the human body are formed of CaPO4.
Structurally, they occur mainly in the form of poorly
crystalline, non-stoichiometric, Na-, K-, Mg- and carbon-
ate-containing CDHA (Young 1975; Danilchenko 2013). It
is often called ‘‘biological apatite’’ (Young 1975; Danil-
chenko 2013; Nakano et al. 2002a; Grynpas and Omelon
2007; Bazin et al. 2014a) [which might be abbreviated as
BAp (Lee et al. 2009; Basaruddin and Takano 2014)],
bioapatite (Eagle et al. 2010; Cherkinsky et al. 2013;
Sˇupova´ 2014) or dahllite (Lowenstam and Weiner 1985;
Fernandez et al. 1998). The latter was named in 1888 by
Bro¨gger and Ba¨ckstro¨m (1890) after the Swedish miner-
alogist brothers Tellef and Johan Martin Dahll.
The main constituents of human bones are CaPO4
(*60–70 wt%), collagen (*20–30 wt%) and water (up to
10 wt%) (Bocchi and Valdre 1993; Skinner 2005; Daculsi
et al. 1997). An interesting cautionary tale on the knowl-
edge development about the structurally incorporated water
in bone apatite is available in literature (Pasteris 2012). The
detailed information on the chemical composition of the
most important human normal calcified tissues is com-
prised in Table 3. One should note that the values men-
tioned in Table 3 are approximate; the main constituents
can vary by a percent or more (Driessens and Verbeeck
1990). Due to the aforementioned effect of lattice flexi-
bility, bones act as both the mineral reservoir of the body
Fig. 2 Samples of natural FA: (a) polycrystalline, (b) single-crys-
talline and (c) a gem. The colors are due to incorporated ions of
transition metals
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and the storage for toxic elements, thus fulfilling two of its
essential physiological roles.
Finally, one should mention, that, in a dissolved state,
CaPO4 are found in many biological liquids, such as blood
serum (Floege et al. 2011), urine (Suller et al. 2005), sweat
(Prompt et al. 1978), and milk (Holt 1982) (Lenton et al.
2015) and, therefore, in dairy products (Gaucheron 2012).
The members of CaPO4 family
In the ternary aqueous system Ca(OH)2–H3PO4–H2O (or
CaO–P2O5–H2O) (Clark 1931; Brown 1992; Martin and
Brown 1997), there are twelve known non-ion-substituted
CaPO4 with the Ca/P molar ratio ranging between 0.5 and
2.0 (Table 1). An anhydrous phase diagram CaO–P2O5 at
temperatures within 200–2200 C is shown in Fig. 3
(Kreidler and Hummel 1967; Carayon and Lacout 2003).
Table 4 comprises crystallographic data of the existing
CaPO4 (Elliott 1994; White and Dong 2003; Mathew and
Takagi 2001). The most important parameters of CaPO4
are the ionic Ca/P ratio, basicity/acidity and solubility. All
these parameters strongly correlate with the solution pH.
The lower the Ca/P molar ratio is, the more acidic and
water-soluble the CaPO4 is (LeGeros 1991; Elliott 1994;
Amjad 1997). Therefore, the Ca/P ratio can be used as a
fingerprint of the CaPO4 phases. One can see that the
solubility ranges from high values for acidic compounds,
such as MCPM, to very low values for basic compounds,
such as apatites, which allowing CaPO4 to be dissolved,
transported from one place to another and precipitated,
when necessary. Crystallization, dissolution and phase
transformation processes of different CaPO4 under various
experimental conditions have been reviewed (Wang and
Nancollas 2008). Regarding applications, some of them
might be used in food industry and, according to the
European classification of food additives, CaPO4 of food
grade quality are known as E341 additive.
Due to the triprotic equilibrium that exists within
orthophosphate-containing solutions, variations in pH alter
the relative concentrations of the four types of anionic
species of orthophosphoric acid (Fig. 4; Lynn and Bonfield
2005) and thus both the chemical composition (Fig. 5;
Leo´n and Jansen 2009) and the amount of the CaPO4 that
are formed by a direct precipitation. The solubility iso-
therms of different CaPO4 are shown in Fig. 6 (Elliott
1994; Amjad 1997; Brown 1992; Martin and Brown 1997;
McDowell et al. 1977; Chow 2009; Ishikawa 2010).
However, in 2009, the classic solubility data of CaPO4
(Elliott 1994; Amjad 1997; Brown 1992; Martin and
Brown 1997; McDowell et al. 1977; Chow 2009; Ishikawa
2010) were mentioned to be inappropriate (Pan and Darvell
2009a). According to the authors of the latter study, all
previous solubility calculations were based on simplifica-
tions, which were only crudely approximate. The problem
lies in incongruent dissolution, leading to phase transfor-
mations and lack of the detailed solution equilibria. Using
an absolute solid-titration approach, the true solubility
Table 2 The principal technological and scientific uses of apatites and other calcium orthophosphates (Rakovan and Pasteris 2015)
Application Properties utilized
Geology
Petrogenetic indicator Major- and trace-element composition
Geochronology (dating) Radionuclide composition, fission tracks
Ore of phosphorus and rare earth elements Composition (P and rare earth elements)
Environmental
Heavy metal and phosphate sequestration Elemental affinity, chemical stability, insolubility
Solid nuclear waste form Thermal and chemical stability, annealing temperature, elemental affinity
Water treatment Elemental affinity, deflocculant
Fertilizer Constituent phosphate
Biology/medicine
Orthopedics Natural constituent of bones
Dentistry Natural constituent of teeth
Nanoparticle drug delivery agent Size, morphology, structure, solubility, biocompatibility
Prosthetic coating, bone and tooth replacement media Compositional and structural similarity to mineral in bones and teeth
Materials
Phosphors Optical emission
Lasers Optical emission and lasing behavior
Gems Color, diaphaneity, chatoyancy
Prog Biomater (2016) 5:9–70 13
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isotherm of HA was found to lie substantially lower than
previously reported. In addition, contrary to a wide belief,
DCPD appeared not to be the most stable phase below pH
*4.2, where CDHA was less soluble (Pan and Darvell
2009a).
A brief description of all known CaPO4 (Table 1) is
given below.
MCPM
Monocalcium phosphate monohydrate [Ca(H2PO4)2H2O;
the IUPAC name is calcium dihydrogen orthophosphate
monohydrate] is both the most acidic and water-soluble
CaPO4. Although acidic CaPO4 in general were known by
1795 as ‘‘super-phosphate of lime’’ (Fourcroy 1804), their
differentiation started in 1800s. Namely, by 1807,
researchers first prepared a calcium phosphate, which could
be attributed to MCPM (Aikin and Aikin 1807).
MCPM crystallizes from aqueous solutions containing
dissolved ions of H2PO4
- and Ca2? at the Ca/P ratio *0.5
and solution pH below *2.0. Besides, MCPM might be
precipitated from aqueous solutions containing organic
solvents (Boonchom 2009; Kongteweelert et al. 2013). At
temperatures above *100 C, MCPM releases a molecule
of water and transforms into MCPA but at temperatures
[*500 C MCPA further transforms into Ca(PO3)2
(Tynsuaadu 1990). The results of the spectroscopic inves-
tigations of MCPM are available in literature (Xu et al.
1998).
Due to high acidity and solubility, MCPM is never
found in biological calcifications. Moreover, pure MCPM
is not biocompatible with bones (Ko¨ster et al. 1977).
However, in medicine MCPM is used as a component of
several self-hardening CaPO4 formulations (Huan and
Chang 2009; Dorozhkin 2013b). In addition, MCPM is
used as a nutrient, acidulant and mineral supplement for
food, feed and some beverages (Budavari et al. 1996; Stein
et al. 2008). Coupled with NaHCO3, MCPM is used as a
leavening agent for both dry baking powders and bakery
dough. MCPM might be added to salt-curing preserves,
Table 3 Comparative composition and structural parameters of inorganic phases of adult human calcified tissues
Enamel Dentine Cementum Bone HA
Composition (wt%)
Calciuma 36.5 35.1 *35 34.8 39.6
Phosphorus (as P)a 17.7 16.9 *16 15.2 18.5
Ca/P (molar ratio)a 1.63 1.61 *1.65 1.71 1.67
Sodiuma 0.5 0.6 c 0.9 –
Magnesiuma 0.44 1.23 0.5–0.9 0.72 –
Potassiuma 0.08 0.05 c 0.03 –
Carbonate (as CO3
2-)b 3.5 5.6 c 7.4 –
Fluoridea 0.01 0.06 Up to 0.9 0.03 –
Chloridea 0.30 0.01 c 0.13 –
Pyrophosphate (as P2O7
4-)b 0.022 0.10 c 0.07 –
Total inorganicb 97 70 60 65 100
Total organicb 1.5 20 25 25 –
Waterb 1.5 10 15 10 –
Crystallographic properties: lattice parameters (±0.003 A˚)
a-axis (A˚) 9.441 9.421 c 9.41 9.430
c-axis (A˚) 6.880 6.887 c 6.89 6.891
Crystallinity index (HA = 100) 70–75 33–37 *30 33–37 100
Typical crystal sizes (nm) (Lowenstam and Weiner 1989;
Weiner and Wagner 1998)
100 lm 9 50 9 50 35 9 25 9 4 c 50 9 25 9 4 200–600







Elastic modulus (GPa) 80 23.8 ± 3.7 15.0 ± 3.6 0.34–13.8 10
Tensile strength (MPa) 10 100 c 150 100
Due to the considerable variation found in biological samples, typical values are given in these cases (LeGeros 1991; Daculsi et al. 1997)
a Ashed samples
b Unashed samples
c Numerical values were not found in the literature but they should be similar to those for dentine
14 Prog Biomater (2016) 5:9–70
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pickled and marinated foods. In addition, MCPM might be
added to tooth pastes and chewing gums (Dorozhkin
2013c). Besides, MCPM might be added to ceramics and
glasses, while agriculture is the main consumer of a
technical grade MCPM, where it is used as a fertilizer,
triple superphosphate (Nasri et al. 2015).
MCPA (or MCP)
Monocalcium phosphate anhydrous [Ca(H2PO4)2; the
IUPAC name is calcium dihydrogen orthophosphate
anhydrous] is the anhydrous form of MCPM. Although
MCPM has been known since 1807 (Dorozhkin 2012a,
2013a), MCPA was differentiated as ‘‘tetra-hydrogen cal-
cium phosphate, H4Ca(PO4)2’’ by 1879 (Roscoe and
Schorlemmer 1879). It crystallizes under the same condi-
tions as MCPM but at temperatures above *100 C (e.g.,
Fig. 3 Phase diagram of the system CaO–P2O5 (C=CaO, P=P2O5) at
elevated temperatures. Here: C7P5 means 7CaO5P2O5; other abbre-
viations should be written out in the same manner. Reprinted from
Refs. (Kreidler and Hummel 1967; Carayon and Lacout 2003) with
permission
Table 4 Crystallographic data of calcium orthophosphates (Elliott 1994; White and Dong 2003; Mathew and Takagi 2001)
Compound Space group Unit cell parameters Za Density
(g cm-3)
MCPM Triclinic P 1 a = 5.6261 (5), b = 11.889 (2), c = 6.4731 (8) A˚, a = 98.633 (6)8,
b = 118.262 (6)8, c = 83.344 (6)8
2 2.23
MCPA Triclinic P 1 a = 7.5577 (5), b = 8.2531 (6), c = 5.5504 (3) A˚, a = 109.87 (1)8,
b = 93.68 (1)8, c = 109.15 (1)8
2 2.58
DCPD Monoclinic Ia a = 5.812 (2), b = 15.180(3), c = 6.239 (2) A˚, b = 116.42 (3)8 4 2.32
DCPA Triclinic P 1 a = 6.910 (1), b = 6.627 (2), c = 6.998 (2) A˚, a = 96.34 (2)8, b = 103.82
(2)8, c = 88.33 (2)8
4 2.89
OCP Triclinic P 1 a = 19.692 (4), b = 9.523 (2), c = 6.835 (2) A˚, a = 90.15 (2)8, b = 92.54
(2)8, c = 108.65 (1)8
1 2.61
a-TCP Monoclinic P21/a a = 12.887 (2), b = 27.280 (4), c = 15.219 (2) A˚, b = 126.20 (1)8 24 2.86
b-TCP Rhombohedral R3cH a = b = 10.4183 (5), c = 37.3464 (23) A˚, c = 120 21b 3.08
HA Monoclinic P21/b or
hexagonal P63/m
a = 9.84214 (8), b = 2a, c = 6.8814 (7) A˚, c = 120 (monoclinic)




FA Hexagonal P63/m a = b = 9.367, c = 6.884 A˚, c = 1208 2 3.20
OA Hexagonal P 6 a = b = 9.432, c = 6.881 A˚, a = 90.3, b = 90.0, c = 119.9 1 *3.2
TTCP Monoclinic P21 a = 7.023 (1), b = 11.986 (4), c = 9.473 (2) A˚, b = 90.90 (1)8 4 3.05
a Number of formula units per unit cell
b Per the hexagonal unit cell
Fig. 4 pH variation of ionic concentrations in triprotic equilibrium
for orthophosphoric acid solutions. Reprinted from Ref. (Lynn and
Bonfield 2005) with permission
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from concentrated hot mother liquors during fertilizer
production). In addition, MCPA might be prepared from
MCPM by dehydration. Furthermore, it might be also
prepared at ambient temperatures by crystallization in
water-restricted or non-aqueous systems. Like MCPM,
MCPA never appears in calcified tissues and is not bio-
compatible due to its acidity. There is no current applica-
tion of MCPA in medicine. Due to the similarity with
MCPM, in many cases, MCPA might be used instead of
MCPM; however, highly hydroscopic properties of MCPA
reduce its commercial applications (Becker 1989; Budavari
et al. 1996).
DCPD
Dicalcium phosphate dihydrate [CaHPO42H2O; the
IUPAC name is calcium hydrogen orthophosphate dihy-
drate; the mineral brushite] has been known since, at least,
1804 (Fourcroy 1804). As a mineral, brushite was first
discovered in phosphatic guano from Avis Island (Car-
ibbean) in 1865 (Moore 1865) and named to honor an
American mineralogist Prof. George Jarvis Brush
(1831–1912), Yale University, New Haven, Connecticut,
USA.
DCPD can be easily crystallized from aqueous solutions
containing dissolved ions of HPO4
2- and Ca2? at the Ca/P
ratio *1 and solution pH within *2.0\ pH\*6.5
(Hamai et al. 2013). Other preparation techniques such as
neutralization of H3PO4 and/or MCPM solutions by CaO,
CaCO3 or more basic CaPO4 (a- or b-TCP, CDHA, HA,
TTCP) are also known. Interestingly, that precipitation of
DCPD by mixing a Ca(OH)2 suspension and a H3PO4
solution in the equimolar quantities was found to occur in
five stages, being HA the first precipitated phase (Ferreira
et al. 2003; Oliveira et al. 2007). Besides, DCPD might be
prepared in gels (Sivkumar et al. 1997; Madhurambal et al.
2009). DCPD transforms into DCPA at temperatures above
*80 C and this transformation is accompanied by
*11 % decrease in volume (MacDowell et al. 1971) and
Fig. 5 Various types of CaPO4 obtained by neutralizing of
orthophosphoric acid by calcium hydroxide. The Ca/P values of the
known types of CaPO4 (Table 1) are reported in the figure. The
solubility of CaPO4 in water decreases drastically from left to right,
HA being the most insoluble and stable phase. Reprinted from Ref.
(Leo´n and Jansen 2009) with permission
Fig. 6 Top: a 3D version of the classical solubility phase diagrams
for the ternary system Ca(OH)2–H3PO4–H2O. Reprinted from Ref.
(Chow 2009) with permission. Middle and bottom: solubility phase
diagrams in two-dimensional graphs, showing two logarithms of the
concentrations of (a) calcium and (b) orthophosphate ions as a
function of the pH in solutions saturated with various salts. Reprinted
from Ref. (Ishikawa 2010) with permission
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structural changes (Landin et al. 1994). The value for DrG
for DCPD ? DCPA transformation is -1.032 kJ/mol
(Landin et al. 1994). Briefly, DCPD crystals consist of
CaPO4 chains arranged parallel to each other, while lattice
water molecules are interlayered between them (Curry and
Jones 1971). Liquid ordering at the {010} DCPD/water
interface was determined (Arsic et al. 2004). In 2009, data
on DCPD solubility were updated by solid titration tech-
nique (Pan and Darvell 2009b). The optical properties of
DCPD were described (Lundager-Madsen 2008), while
many additional data on DCPD including a good drawing
of its atomic structure might be found in Ref. (Qiu and
Orme 2008).
DCPD is of biological importance because it is often
found in pathological calcifications (dental calculi, crys-
talluria, chondrocalcinosis and urinary stones) and some
carious lesions (LeGeros 1991, 2001; O’Neill 2007). It was
proposed as an intermediate in both bone mineralization
and dissolution of enamel in acids (dental erosion)
(LeGeros 1991, 2001; O’Neill 2007). In medicine, DCPD
is used in self-setting CaPO4 formulations (Dorozhkin
2013b) and as an intermediate for tooth remineralization.
DCPD is added to toothpaste both for caries protection (in
this case, it is often coupled with F-containing compounds
such as NaF and/or Na2PO3F) and as a gentle polishing
agent (Dorozhkin 2013c). Other applications include a
flame retardant (Mostashari et al. 2006), a slow release
fertilizer, using in glass production, as well as calcium
supplement in food, feed and cereals. In food industry, it
serves as a texturizer, bakery improver and water retention
additive. In diary industry, DCPD is used as a mineral
supplement. In addition, plate-like crystals of DCPD might
be used as a non-toxic, anticorrosive and passivating pig-
ment for some ground coat paints (Budavari et al. 1996).
DCPA (or DCP)
Dicalcium phosphate anhydrous (CaHPO4; the IUPAC
name is calcium hydrogen orthophosphate anhydrate; the
mineral monetite) is the anhydrous form of DCPD.
Although DCPD has been known since, at least, 1804
(Dorozhkin 2012a, 2013a), DCPA was differentiated as
‘‘mono-hydrogen CaPO4, HCaPO4’’ by 1879 (Roscoe and
Schorlemmer 1879). As a mineral, monetite was first
described in 1882 in rock-phosphate deposits from the
Moneta (now Monito) Island (archipelago of Puerto Rico),
which contains a notable occurrence (Shepard 1882).
Due to the absence of water inclusions, DCPA is less
soluble than DCPD (Table 1). Like DCPD, DCPA can be
crystallized from aqueous solutions containing Ca/P ratio
*1 at solution pH within *2.0\ pH\*6.5 but at
temperatures[*90 C. In addition, DCPA might be pre-
pared by dehydration of DCPD. Furthermore, it might be
also prepared at ambient temperatures in water-restricted or
non-aqueous systems, such as gels (Sivkumar et al. 1997),
ethanol (Tas 2009), as well as in the oil-in-water and water-
in-oil systems (Chen et al. 2005). DCPA is physically
stable and resisted hydration even when dispersed in water
for over 7 months in the temperature range of 4–50 C
(Miyazaki et al. 2009). A calcium-deficient DCPA was also
prepared. It might be sintered at *300 C (Eshtiagh-
Hosseini et al. 2008). Unlike DCPD, DCPA occurs in
neither normal nor pathological calcifications. It is used in
self-setting CaPO4 formulations (Dorozhkin 2013b).
Besides, DCPA might be implanted as bioceramics
(Tamimi et al. 2010). Other applications include using as a
polishing agent, a source of calcium and phosphate in
nutritional supplements (e.g., in prepared breakfast cereals,
enriched flour and noodle products), a tableting aid
(Takami et al. 1996) and a toothpaste component (Dor-
ozhkin 2013c). In addition, it is used as a dough condi-
tioner in food industry (Budavari et al. 1996). DCPA of a
technical grade of purity might be used as a fertilizer
(Habashi 2011).
OCP
Octacalcium phosphate [Ca8(HPO4)2(PO4)45H2O; the
IUPAC name is tetracalcium hydrogen orthophosphate
diorthophosphate pentahydrate, another name is octacal-
cium bis(hydrogenphosphate) tetrakis(phosphate) pen-
tahydrate] is often found as an unstable transient
intermediate during the precipitation of the thermody-
namically more stable CaPO4 (e.g., CDHA) in aqueous
solutions. To the best of my findings (Dorozhkin 2012a,
2013a), OCP has been known since, at least, 1843, when
Percy published a paper (Percy 1843), in which he
described formation of ‘‘a new hydrated phosphate of
lime’’ with a chemical formula 2CaO ? PO5 ? 6HO, in
which ‘‘1 equiv. water being basic and 5 constitutional’’.
However, according to Bjerrum (Bjerrum 1958), a CaPO4
with the OCP composition was first described by Berzelius
in 1836.
The preparation techniques of OCP are available in lit-
erature (LeGeros 1985; Nakahira et al. 2001; Arellano-
Jime´nez et al. 2009; Suzuki 2010a). Briefly, to prepare
OCP, Ca- and PO4-containing chemicals must be mixed to
get the supersaturated aqueous solutions with the Ca/P ratio
equal to 1.33. Typically, OCP crystals are smaller if
compared to DCPD ones, extremely platy and almost
invariably twinned. However, OCP might be non-stoi-
chiometric and be either Ca-deficient (down to Ca/
P = 1.26) or include excessive calcium (up to Ca/
P = 1.48) in the structure (Suzuki 2010a). It has been
proposed that the structure of a non-stoichiometric OCP
contains an excess of hydrogen, resulting in a non-
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stoichiometric chemical formula Ca16H4?x(PO4)12(-
OH)x(10 - x)H2O, which resembles the structure of HA
even more closely than previously anticipated (Mathew
et al. 1988). Furthermore, a partially hydrolyzed form of
OCP with Ca/P molar ratio of 1.37 might be prepared
(Suzuki 2010a; Miyatake et al. 2009). At solution
pH = 7.2 and temperature 60 C, the full hydrolysis of
OCP into CDHA occurs within *6 h (Arellano-Jime´nez
et al. 2009). Ion-substituted OCP might be prepared as well
(Matsunaga 2008a; Boanini et al. 2010a).
The triclinic structure of OCP displays apatitic layers
(with atomic arrangements of calcium and orthophosphate
ions similar to those of HA) separated by hydrated layers
(with atomic arrangements of calcium and orthophosphate
ions similar to those in DCPD) (LeGeros 1991; Elliott
1994; Amjad 1997; Suzuki 2010a). A similarity in crystal
structure between OCP and HA (Brown 1962; Brown et al.
1962) is one reason that the epitaxial growth of these
phases is observed. It is generally assumed that, in solu-
tions, the hydrated layer of the (100) face is the layer most
likely exposed to solution. The water content of OCP
crystals is *20 % that of DCPD and this is partly
responsible for its lower solubility. The latest data on OCP
structure (Davies et al. 2012) and solubility (Pan and
Darvell 2009c) are available.
OCP is of a great biological importance because it is one
of the stable components of human dental and urinary
calculi (Chow and Eanes 2001; Kakei et al. 2009). OCP
was first proposed by W. E. Brown to participate as the
initial phase in enamel mineral formation and bone for-
mation through subsequent precipitation and stepwise
hydrolysis of OCP (Brown 1962, 1966; Brown et al. 1962).
It plays an important role in formation of apatitic
biominerals in vivo (Suzuki 2010b). A ‘‘central OCP
inclusion’’ (also known as ‘‘central dark line’’) is seen by
transmission electron microscopy in many biological apa-
tites and in synthetically precipitated CDHA (Iijima et al.
1996; Bodier-Houlle´ et al. 1998; Rodrı´guez-Herna´ndez
et al. 2005). Although OCP has not been observed in
vascular calcifications, it has been strongly suggested as a
precursor phase to biological apatite found in natural and
prosthetic heart valves (Tomazic et al. 1994; Nancollas and
Wu 2000). In surgery, OCP is used for implantation into
bone defects (Suzuki et al. 2006; Kikawa et al. 2009;
Murakami et al. 2010; Suzuki 2013). For the comprehen-
sive information on OCP, the readers are referred to other
reviews (Suzuki 2010a; Chow and Eanes 2001; Suzuki
2013).
b-TCP
b-tricalcium phosphate [b-Ca3(PO4)2; the IUPAC name is
tricalcium diorthophosphate beta, other names are CaPO4
tribasic beta or tricalcium bis(orthophosphate) beta] is one
of the polymorphs of TCP. Although CaPO4 with the
composition close to that of TCP, CDHA and HA were
known in 1770s (Dorozhkin 2012a, 2013a), a- and b-
polymorphs of TCP were differentiated only by 1932
(Bredig et al. 1932; Tro¨mel 1932).
b-TCP cannot be precipitated from aqueous solutions. It
is a high-temperature phase, which can be prepared at
temperatures above *800 C by thermal decomposition of
CDHA or by solid-state interaction of acidic CaPO4, e.g.,
DCPA, with a base, e.g., CaO. In all cases, the chemicals
must be mixed in the proportions to get the Ca/P ratio equal
to 1.50. However, b-TCP can also be prepared at relatively
low temperatures (*150 C) by precipitation in water-free
mediums, such as ethylene glycol (Tao et al. 2008, 2009).
Apart from the chemical preparation routes, ion-substituted
b-TCP can be prepared by calcining of bones (Hou et al.
2008; Santos et al. 2012): such type of CaPO4 is occa-
sionally called ‘‘bone ash’’ (Lee et al. 2013). At tempera-
tures above *1125 C, b-TCP is transformed into a high-
temperature phase a-TCP. Being the stable phase at room
temperature, b-TCP is less soluble in water than a-TCP
(Table 1). Both ion-substituted (Ito and LeGeros 2008;
Kannan et al. 2009, 2010; Quillard et al. 2012) and
organically modified (Karlinsey and Mackey 2009; Kar-
linsey et al. 2010a, b) forms of b-TCP can be synthesized,
as well. The modern structural data on b-TCP are available
in Refs. (Yashima et al. 2003; Yin et al. 2003; Liang et al.
2010; Zhai and Wu 2010), Raman spectra of b-TCP might
be found if Ref. (Zhai et al. 2015), while solubility data—
in Ref. (Pan and Darvell 2009d). Furthermore, an ability of
b-TCP to store an electrical charge by electrical polariza-
tion was studied and this material was found to have a
suitable composition and structure for both ion conduction
and charge storage (Wang et al. 2010).
Pure b-TCP never occurs in biological calcifications.
Only a Mg-substituted form [b-TCMP—b-tricalcium
magnesium phosphate, b-(Ca,Mg)3(PO4)2, which is often
called whitlockite to honor Mr. Herbert Percy Whitlock
(1868–1948), an American mineralogist, the curator of the
American Museum of Natural History, New York City,
New York, USA (Frondel 1941)] is found. Since b-TCMP
is less soluble than b-TCP (Li et al. 2009a), it is formed
instead of b-TCP in dental calculi and urinary stones,
dentineal caries, salivary stones, arthritic cartilage, as well
as in some soft-tissue deposits (LeGeros 1991, 2001;
O’Neill 2007; Kodaka et al. 1988; Reid and Andersen
1993; Scotchford and Ali 1995; P’ng et al. 2008). How-
ever, it has not been observed in enamel, dentine or bone.
In medicine, b-TCP is used in the self-setting CaPO4 for-
mulations (Dorozhkin 2013b) and other types of bone
grafts (Hou et al. 2008; Horch et al. 2006; Ogose et al.
2006; Kamitakahara et al. 2008; Liu et al. 2008; Epstein
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2009; Liu and Lun 2012). Dental applications of b-TCP are
also known. For example, b-TCP is added to some brands
of toothpaste as a gentle polishing agent (Dorozhkin
2013c). Multivitamin complexes with CaPO4 are widely
available in the market and b-TCP is used as the calcium
phosphate there. In addition, b-TCP serves as a texturizer,
bakery improver and anti-clumping agent for dry powdered
food (flour, milk powder, dried cream, cocoa powder).
Besides, b-TCP is added as a dietary or mineral supplement
to food and feed (Gu¨ngo¨rmu¨s¸ et al. 2010). Occasionally, b-
TCP might be used as inert filler in pelleted drugs. Other
applications comprise porcelains, pottery, enamel, using as
a component for mordants and ackey, as well as a polymer
stabilizer (Budavari et al. 1996). b-TCP of a technical
grade (as either calcined natural phosphorites or bone dust)
is used as a slow release fertilizer for acidic soils (Becker
1989).
To conclude, one should briefly mention on an existence
of c-TCP polymorph, naturally known as tuite, which was
named after Prof. Guangzhi Tu (born in 1920), a founding
director of the Guangzhou Institute of Geochemistry,
Chinese Academy of Sciences, Guangzhou, China. Tuite
appears to be a high-pressure polymorph of whitlockite
with an empirical formula Ca2:51Na0:28Mg0:27Fe
2þ
0:02
PO4ð Þ2:02. Pure c-TCP polymorph can be synthesized from
b-TCP at pressures above *4 GPa and temperatures above
*1000 C (Murayama et al. 1986; Xie et al. 2003; Zhai
et al. 2009, 2014).
a-TCP
a-Tricalcium phosphate [a-Ca3(PO4)2; the IUPAC name is
tricalcium diorthophosphate alpha, other names are CaPO4
tribasic alpha or tricalcium bis(orthophosphate) alpha] is
another polymorph of TCP, which was differentiated by
1932 (Bredig et al. 1932; Tro¨mel 1932). a-TCP is also a
high-temperature phase; therefore, it cannot be precipitated
from aqueous solutions either. Thus, a-TCP is usually
prepared by the same techniques as b-TCP (see the pre-
vious section) but, since the b-TCP ? a-TCP transition
temperature is *1125 C (Welch and Gutt 1961), calcin-
ing is performed at temperatures above *1200 C (Jokic
et al. 2007). Consequently, a-TCP is often considered as a
high-temperature polymorph of b-TCP. However, data are
available that a-TCP might be prepared at lower temper-
atures. Namely, at the turn of the millennium, the previ-
ously forgotten data that the presence of silicates stabilized
a-TCP at temperatures of 800–1000 C (Nurse et al. 1959)
were rediscovered again. Such type of a-TCP is called
‘‘silica stabilized a-TCP’’ (Sayer et al. 2003; Reid et al.
2005, 2006). Furthermore, sometimes, a-TCP might be
prepared at even lower temperatures (*700 C) by a
thermal decomposition of low-temperature ACPs (Kana-
zawa et al. 1982).
Although a-TCP and b-TCP have exactly the same
chemical composition, they differ by the crystal structure
(Table 4) and solubility (Table 1). In the absence of
humidity, both polymorphs of TCP are stable at room
temperatures; however, according to a density functional
study, stability of b-TCP crystal lattice exceeds that of a-
TCP (Yin et al. 2003). Therefore, of them, a-TCP is more
reactive in aqueous systems, has a higher specific energy
and in aqueous solutions it can be hydrolyzed to CDHA
(TenHuisen and Brown 1998; Durucan and Brown 2000,
2002). Milling was found to increase the a-TCP reactivity
even more (Camire´ et al. 2005). Although, a-TCP never
occurs in biological calcifications, in medicine, it is used as
a component of self-setting CaPO4 formulations (Budavari
et al. 1996). On the other hand, the chemically pure a-TCP
has received not much interest in the biomedical field
(Kamitakahara et al. 2008). The disadvantage for using a-
TCP is its quick resorption rate (faster than formation of a
new bone), which limits its application in this area. How-
ever, the silicon stabilized a-TCP (more precisely as a
biphasic composite with HA) has been commercialized as a
starting material to produce bioresorbable porous ceramic
scaffolds to be used as artificial bone grafts (Sayer et al.
2003; Reid et al. 2005, 2006). Upon implantation, a-TCP
tends to convert to CDHA, which drastically reduces fur-
ther degradation rate. Theoretical insights into bone graft-
ing properties of the silicon-stabilized a-TCP might be
found in Ref. (Yin and Stott 2005). The structure of a-TCP
is well described in literature (Yin et al. 2003; Liang et al.
2010), while the surface and adsorption properties are
available in Ref. (Yin and Stott 2006). Similar to b-TCP, a-
TCP of a technical grade might be used slow release fer-
tilizer for acidic soils (Budavari et al. 1996).
To conclude, one should briefly mention on an existence
of a0-TCP polymorph, which was discovered in 1959
(Nurse et al. 1959). However, this TCP polymorph lacks of
any practical interest because it only exists at temperatures
between *1450 C and its melting point (*1756 C). It
reverts to a-TCP polymorph by cooling below the transi-
tion temperature. Additional details on a-TCP are available
in the topical review (Carrodeguas and de Aza 2011).
ACP
Amorphous calcium phosphates (ACPs) represent a special
class of CaPO4 salts, having variable chemical but rather
identical glass-like physical properties, in which there are
neither translational nor orientational long-range orders of
the atomic positions. To the best of my findings (Dorozhkin
2012a, 2013a), ACP was first prepared in 1845 (Jones
1845). Nevertheless, until recently (Dorozhkin 2012c),
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ACP has often been considered as an individual CaPO4
compound with a variable chemical composition, while, in
reality, ACP is just an amorphous state of other CaPO4.
Therefore, in principle, all compounds mentioned in
Table 1 might be somehow fabricated in an amorphous
state but, currently, only few of them (e.g., an amorphous
TCP) are known (Dorozhkin 2012c). Thus, strictly speak-
ing, ACP should be excluded from Table 1. Furthermore,
since ACPs do not have the definite chemical composition,
the IUPAC nomenclature is not applicable to describe
them.
Depending on the production temperatures, all types of
ACP are divided into two major groups: low-temperature
ACPs (prepared in solutions, usually aqueous ones) and
high-temperature ACPs (Dorozhkin 2012c). Low-temper-
ature ACPs (described by the chemical formula CaxHy(-
PO4)znH2O, n = 3–4.5; 15–20 % H2O) are often
encountered as a transient precursor phase during precipi-
tation of other CaPO4 in aqueous systems. Usually, an ACP
is the first phase precipitated from supersaturated solutions
(the higher supersaturation, the better) prepared by rapid
mixing of solutions containing ions of calcium and
orthophosphate (Elliott 1994; Dorozhkin 2012c). Such
ACP precipitates usually look like spherical particles with
diameters in the range 200–1200 A˚ without a definite
structure. Generally, the ACP particles are smaller if pre-
pared under conditions of high supersaturation and/or high
pH, while for a given pH, higher temperatures give larger
particles (Blumenthal et al. 1972). The freshly precipitated
ACPs contain 10–20 % by weight of tightly bound water,
which is removed by vacuum drying at elevated tempera-
ture (Posner and Betts 1975). The amorphization degree of
ACPs increases with the concentration increasing of Ca-
and PO4-containing solutions, as well as at a high solution
pH and a low crystallization temperature. A continuous
gentle agitation of as precipitated ACPs in the mother
solution, especially at elevated temperatures, results in a
slow recrystallization and formation of better crystalline
CaPO4, such as CDHA (LeGeros 1991; Elliott 1994). In
addition, other production techniques of ACPs are known
(Dorozhkin 2012c).
The lifetime of ACPs in aqueous solutions was reported
to be a function of the presence of additive molecules and
ions, pH, ionic strength and temperature. In addition,
confinement was found to increase their lifetime (Wang
et al. 2014a). Thus, ACPs may persist for appreciable
periods and retain the amporphous state under some
specific experimental conditions (Termine et al. 1970). The
chemical composition of ACPs strongly depends on the
solution pH and the concentrations of mixing solutions. For
example, ACPs with Ca/P ratios in the range of 1.18
(precipitated at solution pH = 6.6) to 1.53 (precipitated at
solution pH = 11.7) (Elliott 1994, 1998) and even to 2.5
(LeGeros 1991, 2001; O’Neill 2007) were described. In
deed and not in name, these data mean that various types of
CaPO4 were prepared in an amorphous state (Dorozhkin
2012c). It should be noted that unsubstituted ACPs are
unstable in aqueous solutions and even when stored dry
they tend to transform into more crystalline CaPO4, such as
poorly crystalline CDHA. The presence of poly(ethylene
glycol) (Li and Weng 2007), ions of pyrophosphate, car-
bonate and/or magnesium in solutions during the crystal-
lization promotes formation of ACPs and slows down their
further transformation, while the presence of fluoride has
the opposite effect (LeGeros 1991; Elliott 1994; Amjad
1997; Daculsi et al. 1997; Tadic et al. 2002). In general,
low-temperatures ACPs heated to *550 C (so that all
volatiles have already escaped) remain amorphous, but
further heating above *650 C causes their transformation
into crystalline CaPO4, such as a- or b-TCP, HA, mixtures
thereof, depending on the Ca/P ratio of the ACP heated.
High-temperature ACPs might be prepared using high
energy processing at elevated temperatures (Dorozhkin
2012c). This method is based on a rapid quenching of
melted CaPO4 occurring, e.g., during plasma spraying of
HA (Carayon and Lacout 2003; Keller and Dollase 2000;
Kumar et al. 2004). A plasma jet, possessing very high
temperatures (*5000 to *20,000 C), partly decomposes
HA, which results in formation of a complicated mixture of
products, some of which would be ACPs. Obviously, all
types of high-temperature ACPs are definitively anhydrous
contrary to the precipitated ACPs. Unfortunately, no ade-
quate chemical formula is available to describe the high-
temperature ACPs.
In general, as all amorphous compounds are character-
ized by a lack of long-range order, it is problematic to
discuss the structure of ACPs (they are X-ray amorphous).
Concerning a short-range order (SRO) in ACPs, it exists,
just due to the nature of chemical bonds. Unfortunately, in
many cases, the SRO in ACPs is uncertain either, because
it depends on many variables, such as Ca/P ratio, prepa-
ration conditions, storage and admixtures. Infrared spectra
of ACPs show broad featureless phosphate absorption
bands. Electron microscopy of freshly precipitated ACPs
usually shows featureless nearly spherical particles with
diameters in the range of 20–200 nm. However, there is a
questionable opinion that ACPs might have an apatitic
structure but with a crystal size so small, that they are
X-ray amorphous. This is supported by X-ray absorption
spectroscopic data (EXAFS) on biogenic and synthetic
samples (Harries et al. 1986, 1987; Taylor et al. 1998;
Peters et al. 2000). On the other hand, it was proposed that
the basic structural unit of the precipitated ACPs is a 9.5 A˚
diameter, roughly spherical cluster of ions with the com-
position of Ca9(PO4)6 (Fig. 7; Elliott 1994, 1998; Posner
et al. 1980; Boskey 1997). These clusters were found
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experimentally as first nuclei during the crystallization of
CDHA and a model was developed to describe the crys-
tallization of HA as a step-wise assembly of these units
(Onuma and Ito 1998) [see ‘‘HA (or HAp, or OHAp)’’].
Biologically, ion-substituted ACPs (always containing ions
of Na, Mg, carbonate and pyrophosphate) are found in soft-
tissue pathological calcifications (e.g., heart valve calcifi-
cations of uremic patients) (LeGeros 1991, 2001; O’Neill
2007).
In medicine, ACPs are used in self-setting CaPO4 for-
mulations (Dorozhkin 2013b). Bioactive composites of
ACPs with polymers have properties suitable for use in
dentistry (Dorozhkin 2012c, 2013c) and surgery (Dor-
ozhkin 2012c; Tadic and Epple 2002). Due to a reasonable
solubility and physiological pH of aqueous solutions, ACPs
appeared to be consumable by some microorganisms and,
due to this reason, it might be added as a mineral supple-
ment to culture media. Non-biomedical applications of
ACPs comprise their using as a component for mordants
and ackey. In food industry, ACPs are used for syrup
clearing. Occasionally, they might be used as inert filler in
pelleted drugs. In addition, ACPs are used in glass and
pottery production and as a raw material for production of
some organic phosphates. To get further details on ACPs,
the readers are referred to special reviews (Dorozhkin
2012c; Boskey 1997; Combes and Rey 2010).
CDHA (or Ca-def HA, or CDHAp)
Calcium-deficient hydroxyapatite [Ca10-x(HPO4)x(PO4)6-
x(OH)2-x (0\ x\ 1)] became known since the earliest
experiments on establishing the chemical composition of
bones performed in 1770s (Dorozhkin 2012a, 2013a).
However, the first appropriate term ‘‘subphosphate of
lime’’ appeared by 1819 (Bache 1819). Other chemical
formulae such as Ca10-x(HPO4)2x(PO4)6-2x(OH)2
(0\ x\ 2), Ca10-x-y(HPO4)x(PO4)6-x(OH)2-x-2y
(0\ x\ 2 and y\ x/2), Ca10-x(HPO4)x(PO4)6-x(-
OH)2-x(H2O)x (0\ x\ 1), and Ca9-x(HPO4)1?2-
x(PO4)5-2x(OH) were also proposed to describe its variable
composition (Elliott 1994). As seen from these formulae,
Ca deficiency is always coupled with both OH deficiency
and protonation of some PO4 groups with simultaneous
formation of the ionic vacancies in the crystal structure
(Wilson et al. 2005). In addition, CDHA often contains
tightly bound water molecules, which might occupy some
of these ionic vacancies. For example, there is an approach
describing a lack of the hydroxide vacancies in CDHA: to
perform the necessary charge compensation of the missing
Ca2? ions, a portion of OH- anions is substituted by
neutral water molecules (Zahn and Hochrein 2008). This
water is removed by vacuum drying at elevated tempera-
ture. Concerning possible vacancies of orthophosphate
ions, nothing is known about their presence in CDHA. It is
just considered that a portion of PO4
3- ions is either pro-
tonated (as HPO4
2-) or substituted by other ions (e.g.,
CO3
2-) (Ivanova and Frank-Kamenetskaya 2001). Since
CDHA does not have any definite chemical composition,
the IUPAC nomenclature is not applicable to describe it.
CDHA can be easily prepared by simultaneous addition
of Ca- and PO4-containing solutions in the proportions to
get Ca/P ratio within 1.50–1.67 into boiling water followed
by boiling the suspension for several hours (an aging
stage). That is why, in literature, it might be called as
‘‘precipitated HA (PHA)’’ (Sinha et al. 2003; Mayer et al.
2003). Besides, it might be prepared by hydrolysis of a-
TCP (TenHuisen and Brown 1998; Durucan and Brown
2000, 2002). Other preparation techniques of CDHA are
known as well (Vallet-Regı´ et al. 1997; Siddharthan et al.
2004; Hutchens et al. 2006; Mochales et al. 2011). During
aging, initially precipitated ACPs are restructured and
transformed into CDHA. Therefore, there are many simi-
larities in the structure, properties and application between
the precipitated in alkaline solutions (pH[ 8) ACPs and
CDHA. Some data indicated on a presence of intermediate
phases during further hydrolysis of CDHA to a more
stable HA-like phase (Bre`s et al. 2005). In general, CDHA
crystals are poorly crystalline and of submicron dimen-
sions. They have a very large specific surface area, typi-
cally 25–100 m2/g. On heating above *700 C, CDHA
with Ca/P = 1.5 converts to b-TCP and that with
1.5\Ca/P\ 1.67 converts into a biphasic composite of
HA and b-TCP (see ‘‘Biphasic, triphasic and multiphasic
CaPO4 formulations’’) (Dorozhkin 2012d). A solid-state
transformation mechanism of CDHA into HA ? b-TCP
biocomposite was proposed (Dorozhkina and Dorozhkin
2002a; Dorozhkin 2003).
The variability in Ca/P molar ratio of CDHA has been
explained through different models: surface adsorption,
lattice substitution and intercrystalline mixtures of HA and
Fig. 7 A model of ACP structure. Reprinted from Ref. (Posner et al.
1980) with permission
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OCP (Rodrı´guez-Lorenzo 2005). Due to a lack of stoi-
chiometry, CDHA is usually doped by other ions (Rey
et al. 2006). The doping extent depends on the counter-ions
of the chemicals used for CDHA preparation. Direct
determinations of the CDHA structures are still missing
and the unit cell parameters remain uncertain. However,
unlike that in ACPs (see ‘‘ACP’’), a long-range order exists
in CDHA. Namely, the following lattice parameters were
reported for CDHA with Ca/P = 1.5: a = 9.4418 (20) A˚
and c = 6.8745 (17) A˚ (Mochales et al. 2011).
Systematic studies of defect constellations in CDHA are
available in literature (Zahn and Hochrein 2008; Liou et al.
2004). As a first approximation, CDHA may be considered
as HA with some ions missing (ionic vacancies) (Brown
and Martin 1999). The more amount of Ca is deficient, the
more disorder, imperfections and vacancies are in the
CDHA structure (Honghui et al. 2007). Furthermore, a
direct correlation between the Ca deficiency and the
mechanical properties of the crystals was found: calcium
deficiency lead to an 80 % reduction in the hardness and
elastic modulus and at least a 75 % reduction in toughness
in plate-shaped HA crystals (Viswanath et al. 2010). More
recently, using first-principles calculations, a reduction in
the elastic constants and moduli of CDHA due to vacancies
was reported (Sun et al. 2013; Bhat et al. 2014). Theoret-
ical investigations of the defect formation mechanism rel-
evant to non-stoichiometry in CDHA are available
elsewhere (Matsunaga 2008b).
Undoped CDHA (i.e., that containing ions of Ca2?,
PO4
3-, HPO4
2- and OH- only) does not exist in biological
systems. However, the ion-substituted CDHA: Na?, K?,





2- for OH-, plus some water forms biological
apatite—the main inorganic part of animal and human
normal and pathological calcifications (LeGeros 1991; Rey
et al. 2006; O’Neill 2007). Therefore, CDHA is a very
promising compound for industrial manufacturing of arti-
ficial bone substitutes (Bourgeois et al. 2003), including
drug delivery applications (Liu et al. 2005). Non-biomed-
ical applications of CDHA are similar to those of ACP and
HA. Interesting that CDHA was found to possess a cat-
alytic activity to produce biogasoline (Tsuchida et al.
2008).
HA (or HAp, or OHAp)
Hydroxyapatite [Ca5(PO4)3(OH), but is usually written as
Ca10(PO4)6(OH)2 to denote that the crystal unit cell com-
prises two molecules; the IUPAC name is pentacalcium
hydroxide tris(orthophosphate)] is the second most
stable and least soluble CaPO4 after FA. Apatites were
recognized as calcium phosphates by, at least, 1789 (Dor-
ozhkin 2012a, 2013a). Here, it is worth noting that
hydroxylapatite would be a more accurate abbreviation
expansion of HA (perhaps, hydroxideapatite would be even
better because it relates to calcium hydroxide) while by
both the medical and material communities HA is usually
expanded as hydroxyapatite.
Chemically pure HA crystallizes in the monoclinic
space group P21/b (Elliott et al. 1973). However, at tem-
peratures above *250 C, there is a monoclinic to
hexagonal phase transition in HA (space group P63/m)
(Elliott 1994, 1998; Mathew and Takagi 2001; Rangavittal
et al. 2000; Kim et al. 2000a). The structural difference
between the two modifications represents the ordered,
head-to-tail arrangement of OH groups located in the
center of every other Ca2 triangle in the monoclinic low-
temperature symmetry and the disordered arrangement of
OH groups, where the head-to-tail and tail-to-head
arrangements alternate throughout the channel in the
hexagonal high-temperature symmetry. This induces
strains that might be compensated by substitutions and/or
ion vacancies. Some impurities, like partial substitution of
hydroxide by fluoride or chloride, stabilize the hexagonal
structure of HA at ambient temperature. Due to this reason,
hexagonal HA is seldom the stoichiometric phase and very
rare single crystals of natural HA always exhibit the
hexagonal space group. The detailed description of the HA
structure was first reported in 1964 (Kay et al. 1964) and its
interpretation in terms of aggregation of Ca9(PO4)6 clus-
ters, the so-called Posner’s clusters, has been widely used
since publication of the article by Posner and Betts (Posner
and Betts 1975).
Due to the exceptional importance of HA for the human
beings, its properties have been thoroughly investigated by
many research groups and further studies are kept going.
Namely, the crystal structure of HA is well described
elsewhere (Elliott 1994; White and Dong 2003; Mathew
and Takagi 2001), the detailed analysis of the electronic
structure, bonding, charge transfer, optical and elastic
properties is also available (Calderin et al. 2003; Rulis
et al. 2004; Snyders et al. 2007; Ching et al. 2009), while
the readers interested in Posner’s clusters are referred to
still other papers (Treboux et al. 2000; Yin and Stott 2003;
Kanzaki et al. 2001). A shell model was developed to study
the lattice dynamics of HA (Calderin et al. 2005), while a
cluster growth model was created to illustrate its growth
(Onuma and Ito 1998). Polarization characteristics (Tanaka
et al. 2010a, b), pyroelectric (Tofail et al. 2009, 2015) and
piezoelectric (Tofail et al. 2015; Bystrov 2015) properties
of HA as well as diffusion of protons inside the HA crystal
lattice (Yashima et al. 2014) were investigated. The ther-
modynamic properties of HA and other types of
orthophosphate-based apatites were summarized (Drouet
2015). First-principles calculations for the elastic proper-
ties of doped HA (Kawabata and Yamamoto 2010) and
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vacancy formation in HA (Matsunaga and Kuwabara 2007)
were performed. Other examples of the computer simula-
tions of the structure and properties of HA are available
elsewhere (de Leeuw 2010; Corno et al. 2010; Slepko and
Demkov 2011; Aquilano et al. 2014, 2015). Finally, an
attempt was performed to explain an array of the curious
characteristics of HA by referring to the hydroxyl ion
channels extending in the direction of the c-axis, through a
crystallographic column created by the overlapping cal-
cium ion triangles (Uskokovic´ 2015).
Many techniques might be utilized for HA preparation;
they can be divided into solid-state reactions and wet
methods (Briak-Ben et al. 2008), which include precipita-
tion, hydrothermal synthesis and hydrolysis of other
CaPO4. However, in all cases, Ca- and PO4-containing
chemicals must be mixed to get the Ca/P ratio strictly equal
to 1.67. Nevertheless, even under the ideal stoichiometric
conditions, the precipitates are generally non-stoichiomet-
ric, suggesting intermediate formation of precursor phases,
such as ACP and CDHA. Usually, unsintered HA is poorly
crystalline and often non-stoichiometric, resembling the
aforementioned CDHA. However, well crystalline HA can
be prepared from aqueous solutions at relatively high
(10–11) pH and elevated ([90 C) temperatures (Markovic
et al. 2004). HA with the Ca/P ratio[1.67 (Ca-rich HA)
might be prepared as well (Bonel et al. 1988). The detailed
information on HA synthesis is available elsewhere (Nar-
asaraju and Phebe 1996; Riman et al. 2002; Koutsopoulos
2002; Norton et al. 2006; Sadat-Shojai et al. 2013). In
addition, there are good reviews on HA solubility, crystal
growth and intermediate phases of HA crystallization
(Rakovan 2002), as well as on HA dissolution (Dorozhkin
2012e).
Pure HA never occurs in biological systems. However,
due to the chemical similarities to bone and teeth mineral
(Table 3), HA is widely used as coatings on orthopedic
(e.g., hip joint prosthesis) and dental implants (Dorozhkin
2013c; Suchanek and Yoshimura 1998; Sun et al. 2001;
Ong and Chan 1999; Dey et al. 2009; Dorozhkin 2015a).
HA bioceramics is very popular as well (Yuan et al. 2009;
Engin and Tas 1999; Mangano et al. 2008). Due to a great
similarity to biological apatite, over a long time HA has
been used in liquid chromatography of nucleic acids, pro-
teins and other biological compounds (Bernardi 1965;
Brand et al. 2008; Hou et al. 2011; Hilbrig and Freitag
2012; Niimi et al. 2014; Pinto et al. 2014) and for drug
delivery purposes (Uskokovic´ and Uskokovic´ 2011; Chen
et al. 2011a; Li et al. 2013; Long et al. 2013; Feng et al.
2013a). Also, HA is added to some brands of toothpaste as
a gentle polishing agent instead of calcium carbonate
(Niwa et al. 2001; Kim et al. 2006). Non-biomedical
applications of HA include its using as an environmental-
friendly filler for elastomers (Pietrasik et al. 2008), a low-
temperature sorbent (Bailliez et al. 2004; Corami et al.
2008) and/or stabilizer (Wang et al. 2014b) of poisonous
chemical elements, a high-temperature sorbent for carbon
dioxide (Landi et al. 2014), both a catalyst (Xu et al. 2010;
Rodrigues et al. 2014) and a carrier for other catalysts
(Domı´nguez et al. 2009; Sun et al. 2009; Vukomanovic´
et al. 2012), a material for ultraviolet light protection
(Holzmann et al. 2009) and sunscreen filter (Piccirillo et al.
2014), as well as a component of various sensors (Nagai
et al. 1988; Petrucelli et al. 1996; Tagaya et al. 2010;
Khairnar et al. 2011). Finally, highly flexible and non-
flammable inorganic paper could be prepared from HA (Lu
et al. 2014a).
FA (or FAp)
Fluorapatite [Ca5(PO4)3F, but is usually written as Ca10(-
PO4)6F2 to denote that the crystal unit cell comprises two
molecules; the IUPAC name is pentacalcium fluoride
tris(orthophosphate)] is the only ion-substituted CaPO4,
considered in this review. Since the presence of 2.5 % of
fluorides in natural apatites was established by 1798
(Dobson 1798), this date might be accepted as the earliest
hearing of FA.
FA is the hardest (five according to the Mohs’ scale of
mineral hardness), most stable and least soluble compound
among all CaPO4 (Table 1). In addition, it is the most
thermally stable CaPO4 with the melting point at
*1650 C (To˜nsuaadu et al. 2012). Perhaps, such ‘‘ex-
treme’’ properties of FA are related to the specific position
of F- ions in the center of Ca(2) triangles of the crystal
structure (Elliott 1994; White and Dong 2003). Due to its
properties, FA is the only CaPO4 that naturally forms large
deposits suitable for the commercial use (McConnell 1973;
Becker 1989; Rakovan and Pasteris 2015; see also Fig. 2).
Preparation techniques of the chemically pure FA are
similar to the aforementioned ones for HA but the synthesis
must be performed in presence of the necessary amount of
F- ions (usually, NaF or NH4F is added). Under some
special crystallization conditions (e.g., in presence of
gelatin or citric acid), FA might form unusual dumbbell-
like fractal morphology that finally are closed to spheres
(Fig. 8; Busch et al. 1999; Wu et al. 2010). In addition, FA
is the only CaPO4, which melts without decomposition;
therefore, big (up to 30 cm long and, for shorter lengths, up
to 1.9 cm wide) single FA crystals might be grown from
FA melts (Mazelsky et al. 1968a; Loutts and Chai 1993).
Similar to that for HA (see CDHA), an existence of CaF2-
deficient FA was also detected but for the crystals grown
from the FA melt only (Mazelsky et al. 1968a; Warren
1972). In addition, FA with an excess of CaF2 was prepared
(Mann and Turner 1972). A hierarchical structure for FA
was proposed (Dorozhkin 2007a). The crystal structure of
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FA for the first time was studied in 1930 (Mehmel 1930;
Naray-Szabo 1930) and is well described elsewhere (Elliott
1994; White and Dong 2003; Mathew and Takagi 2001).
Computer simulations of the FA structure were performed
as well (Li et al. 2015). The detailed analysis of the elec-
tronic structure, bonding, charge transfer and optical
properties of FA (Rulis et al. 2004), as well as its NMR
study under pressure (Pavan et al. 2012) is available as
well. In addition, there are reviews on FA solubility
(Rakovan 2002) and the dissolution mechanism (Dor-
ozhkin 2012e).
FA easily forms solid solutions with HA with any
desired F/OH molar ratio. Such compounds are called
fluorhydroxyapatites (FHA) (Nikcevic et al. 2004; Mon-
tazeri et al. 2010; Zhu et al. 2012) or hydroxyfluorapatites
(HFA) (Rodrı´guez-Lorenzo et al. 2003; Azami et al. 2012)
and described with a chemical formula Ca10(PO4)6(-
OH)2-xFx, where 0\ x\ 2. If the F/OH ratio is either
uncertain or not important, the chemical formula of FHA
and HFA is often written as Ca10(PO4)6(F,OH)2. The lattice
parameters, crystal structure, solubility and other properties
of FHA and HFA lay in between of those for the chemi-
cally pure FA and HA. Namely, the substitution of F for
OH results in a contraction in the a-axis with no significant
change in the c-axis dimensions and greater resolution of
the IR absorption spectra.
Similar to pure HA, pure FA never occurs in biological
systems. Obviously, a lack of the necessary amount of
toxic fluorides (the acute toxic dose of fluoride is *5 mg/
kg of body weight) in living organisms is the main reason
of this fact (pure FA contains 3.7 % mass. F). Enameloid of
shark teeth (Lowenstam and Weiner 1989; Daculsi et al.
1997; Prostak et al. 1993; Dahm and Risnes 1999; Carr
et al. 2006; Enax et al. 2014) and some exoskeletons of
mollusks (Leveque et al. 2004) seem to be the only
exclusions because they contain substantial amounts of
fluoride, with is presented there as ion-substituted, non-
stoichiometric FHA or HFA. Among all normal calcified
tissues of humans, the highest concentration of fluorides is
found in dentine and cementum, while the lowest—in
dental enamel (Table 3). Nevertheless, one should stress
that the amount of fluorides on the very surface of dental
enamel might be substantially increased using fluoride-
containing toothpastes and mouthwashes (Schemehorn
et al. 2011; Hattab 2013). However, in no case, the total
amount of fluorides is enough to form pure FA.
Contrary to the initial expectations (Heling et al. 1981),
chemically pure FA is not used for grafting purposes.
Presumably, this is due to the lowest solubility, good
chemical stability of FA and toxicity of high amounts of
fluorides. However, attempts to test FA-containing for-
mulations (Gineste et al. 1999; Agathopoulos et al. 2003;
Yoon et al. 2005; Bogdanov et al. 2009; Nordquist et al.
2011), ion-substituted FA (Kheradmandfard et al. 2012;
Sharifnabi et al. 2014), FHA (Savarino et al. 2003; Vit-
kovicˇ et al. 2009) and porous FA bioceramics (Chaari et al.
2009) are kept performing. The effect of fluoride contents
in FHA on both osteoblast behavior (Qu and Wei 2006;
Bhadang et al. 2010) and leukemia cells proliferation
(Theiszova et al. 2008) has been described. Non-biomedi-
cal applications of FA include luminescent light tubes
(Davis et al. 1971) and thermometers (Fu et al. 2015), laser
materials (Mazelsky et al. 1968b; Ohlmann et al. 1968) (in
all these cases various dopants are necessary), as well as
catalysts (An et al. 2009).
OA (or OAp, or OXA)
Oxyapatite [Ca10(PO4)6O; the IUPAC name is decacalcium
oxide hexakis(phosphate), mineral voelckerite] is the least
stable and, therefore, the least known CaPO4, which,
probably, does not exist at all. Nevertheless, a name
‘‘voelckerite’’ was introduced in 1912 by A.F. Rogers
(1887–1957) for a hypothetical mineral with the chemical
composition of 3Ca3(PO4)2 ? CaO (Rogers 1912, 1914),
to honor an English agricultural chemist John Christopher
Augustus Voelcker (1822–1884), who, in 1883, first
showed an apparent halogen deficiency in some natural
apatites (Voelcker 1883). Therefore, 1883 might be
accepted as the earliest hearing on OA.
To the best of my findings, phase pure OA has never
been obtained at room temperatures; therefore, its proper-
ties are not well established. Furthermore, still there are
serious doubts that pure OA can exist. Since hydroxyl ions
in HA appear to be the most mobile ones and upon expo-
sure to high temperatures are the first to leave the lattice, a
mixture (or a solid solution?) of OA and HA (so-called
Fig. 8 A biomimetically grown aggregate of FA that was crystallized
in a gelatin matrix. Its shape can be explained and simulated by a
fractal growth mechanism. Scale bar 10 lm. Reprinted from Ref.
(Busch et al. 1999) with permission
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‘‘oxy-HA’’, chemical formula: Ca10(PO4)6(OH)2-2xOxVx,
where V represents an OH- vacancy) might be prepared by
a partial dehydroxylation of HA at temperatures exceeding
*900 C (e.g., during plasma spray of HA) strictly in the
absence of water vapor (Gross et al. 1998; Hartmann et al.
2001; Alberius-Henning et al. 2001; Wang and Dorner-
Reisel 2004; Liu and Shen 2012). It also might be crys-
tallized in glass-ceramics (van’t Hoen et al. 2007). OA is
very unstable and has no stability field in aqueous condi-
tions (Duff 1972). Namely, data are available that oxy-HA
containing less than 25 % HA (i.e., almost OA) during
further dehydration decomposes to a mixture of a-TCP and
TTCP. In addition, OA is very reactive and transforms to
HA in contact with water vapor (HA reconstitution) (Gross
et al. 1998). The largest impediment to active research in
OA is the non-availability of a user-friendly approach to
measure the concentration of hydroxyl ions (Gross and
Pluduma 2012).
Therefore, computer-modeling techniques have been
employed to qualitatively and quantitatively investigate the
dehydration of HA to OA (de Leeuw et al. 2007). OA has
the hexagonal space group symmetry P 6 (174) of cesanite
type (White and Dong 2003), while the space group sym-
metry for partially dehydrated HA was found to change
from hexagonal P63/m to triclinic P 1 when more than ca.
35 % of the structurally bound water had been removed
(Alberius-Henning et al. 2001). On the c-axis, pure OA
should have a divalent ion O2- coupled with a vacancy
instead of two neighboring monovalent OH- ions.
Due to the aforementioned problems with OA prepara-
tion, it cannot be found in biological systems. In addition,
no information on the biomedical applications of OA is
available either. Plasma-sprayed coatings of CaPO4, in
which OA might be present as an admixture phase, seem to
be the only exception (Dorozhkin 2015a).
To conclude, one should mention that various types of
calcium peroxy-HA (oxygenated HA) could be prepared
both in the presence of hydrogen peroxide (Rey et al. 1978)
and by HA heating in an oxygen-rich atmosphere (Zhao
et al. 2000; Yu et al. 2007). Similar to that for OA, none of
them was ever prepared as a phase pure individual com-
pound and no examples of the biomedical applications of
such types of CaPO4 were found.
TTCP (or TetCP)
Tetracalcium phosphate or tetracalcium diorthophosphate
monoxide (Ca4(PO4)2O; the IUPAC name is tetracalcium
oxide bis(orthophosphate); the mineral hilgenstockite) is
the most basic CaPO4, however, its solubility in water is
higher than that of HA (Table 1). TTCP has been known
since 1883 (Hilgenstock 1883), while the mineral
hilgenstockite was named to honor a German metallurgist
Gustav Hilgenstock (1844–1913), who first discovered it in
Thomas slag from blast furnaces (Hilgenstock 1883, 1887).
Its major industrial importance stems from the fact that it is
formed by the reactions between orthophosphates and lime
in the manufacture of iron, and through these reactions,
TTCP has a significant role in controlling the properties of
the metal.
TTCP cannot be precipitated from aqueous solutions. It
can be prepared only under the anhydrous conditions by
solid-state reactions at temperatures above *1300 C, e.g.,
by heating homogenized equimolar quantities of DCPA
and CaCO3 in dry air, or in a flow of dry nitrogen (Elliott
1994, 1998; Kai et al. 2009). These reactions should be
carried out in a dry atmosphere, in vacuum or with rapid
cooling (to prevent uptake of water and formation of HA).
Easily DCPA might be replaced by ammonium
orthophosphates (Romeo and Fanovich 2008; Jalota et al.
2005), while calcium carbonate might be replaced by cal-
cium acetate (Jalota et al. 2005); however, in all cases, Ca/
P ratio must be equal to 2.00. Furthermore, TTCP often
appears as an unwanted by-product in plasma-sprayed HA
coatings, where it is formed as a result of the thermal
decomposition of HA to a mixture of high-temperature
phases of a-TCP, TTCP and CaO (Moseke and Gbureck
2010). Nevertheless, TTCP might be produced at 900 C
by calcining of a precipitated ACP with Ca/P = 2 in vac-
uum; the process is suggested to occur via a intermediate
formation of a mixture of OA ? CaO (Gross and Rozite
2015).
TTCP is metastable: in both wet environment and
aqueous solutions it slowly hydrolyses to HA and calcium
hydroxide (Elliott 1994, 1998; Martin and Brown 1993).
Consequently, TTCP is never found in biological calcifi-
cations. In medicine, TTCP is widely used for preparation
of various self-setting CaPO4 formulations (Dorozhkin
2013b; Moseke and Gbureck 2010); however, to the best of
my knowledge, there is no commercial bone-substituting
product consisting solely of TTCP. For the comprehensive
information on TTCP, the readers are referred to a special
review (Moseke and Gbureck 2010), while the spectra
(Jillavenatesa and Condrate 1997) and solubility (Pan and
Darvell 2009a) of TTCP are well described elsewhere.
To finalize the description of individual CaPO4, one
should mention on an interesting opinion, that all types of
CaPO4 listed in Table 1 might be classified into three
major structural types (Mathew and Takagi 2001; Chow
and Eanes 2001). They comprise: (1) the apatite type,
Ca10(PO4)6X2, which includes HA, FA, OA, CDHA, OCP
and TTCP; (2) the glaserite type, named after the mineral
glaserite, K3Na(SO4)2, which includes all polymorphs of
TCP and, perhaps, ACP; (3) the Ca-PO4 sheet-containing
compounds, which include DCPD, DCPA, MCPM and
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MCPA. According to the authors, a closer examination of
the structures revealed that all available CaPO4 could be
included into distorted glaserite type structures, but with
varying degrees of distortion (Mathew and Takagi 2001;
Chow and Eanes 2001).
Biphasic, triphasic and multiphasic CaPO4
formulations
CaPO4 might form biphasic, triphasic and multiphasic
(polyphasic) formulations, in which the individual com-
ponents cannot be separated from each other. Presumably,
the individual phases of such compositions are homoge-
neously ‘‘mixed’’ at a far submicron level (\0.1 lm) and
strongly integrated with each other. Nevertheless, the
presence of all individual phases is easily seen by X-ray
diffraction technique (Dorozhkin 2012d).
The usual way to prepare multiphasic formulations
consists of sintering non-stoichiometric compounds, such
as ACP and CDHA, at temperatures above *700 C.
Furthermore, a thermal decomposition of the stoichiomet-
ric CaPO4 at temperatures above *1300 C might be used
as well; however, this approach often results in formation
of complicated mixtures of various products including
admixtures of CaO, calcium pyrophosphates, etc. (Dor-
ozhkin 2012d; Nakano et al. 2002b). Namely, transforma-
tion of HA into polyphasic CaPO4 by annealing in a
vacuum occurs as this: the outer part of HA is transformed
into a-TCP and TTCP, while the a-TCP phase of the sur-
face further transforms into CaO. Besides, in the boundary
phase, HA is transformed into TTCP (Nakano et al. 2002b).
Historically, Nery and Lynch with co-workers first used
the term biphasic calcium phosphate (BCP) in 1986 to
describe a bioceramic that consisted of a mixture of HA
and b-TCP (Ellinger et al. 1986). Based on the results of
X-ray diffraction analysis, these authors found that the
‘‘tricalcium phosphate’’ preparation material used in their
early publication (Nery et al. 1975) was in fact a mixture of
*20 % HA and *80 % b-TCP. Currently, only biphasic
and triphasic CaPO4 formulations are known; perhaps,
more complicated formulations will be manufactured in
future. Furthermore, nowadays, multiphasic and/or
polyphasic compositions consisting of high-temperature
phases of CaPO4, such as a-TCP, b-TCP, HA and, perhaps,
high-temperature ACP, OA and TTCP, are known only. No
precise information on multiphasic compositions, contain-
ing MCPM, MCPA, DCPD, DCPA, low-temperature ACP,
OCP and CDHA has been found in literature (Dorozhkin
2012d). Perhaps, such formulations will be produced in
future.
All BCP formulations might be subdivided into two
major groups: those consisting of CaPO4 having either the
same (e.g., a-TCP and b-TCP) or different (e.g., b-TCP
and HA) molar Ca/P ratios. Among all known BCP for-
mulations, BCP consisting of HA and b-TCP is both the
most known and the best investigated (Dorozhkin 2012d).
In 1986, LeGeros in USA and Daculsi in France initiated
the basic studies on preparation of this type of BCP and its
in vitro properties. This material is soluble and gradually
dissolves in the body, seeding new bone formation as it
releases calcium and orthophosphate ions into the biolog-
ical medium. Presently, commercial BCP products of dif-
ferent or similar HA/b-TCP ratios are manufactured in
many parts of the world as bone graft or bone substitute
materials for orthopedic and dental applications under
various trademarks and several manufacturers (Dorozhkin
2012d). A similar combination of a-TCP with HA forms
BCP as well (Reid et al. 2005; Pan et al. 2006; Kui 2007;
Li et al. 2009b).
Recently, the concept of BCP has been extended by
preparation and characterization of biphasic TCP (BTCP),
consisting of a-TCP and b-TCP phases (Wang et al. 2006a;
Li et al. 2007, 2008a). It is usually prepared by heating
ACP precursors (Wang et al. 2006a; Li et al. 2007, 2008a),
in which the a-TCP/b-TCP ratio can be controlled by aging
time and pH value during synthesis of the amorphous
precursor (Li et al. 2007). Furthermore, triphasic formu-
lations, consisting of HA, a-TCP and b-TCP (Vani et al.
2009) or HA, a-TCP and TTCP (Nakano et al. 2002b) have
been prepared (Dorozhkin 2012d).
It is important to recognize, that the major biomedical
properties (such as bioactivity, bioresorbability, osteocon-
ductivity and osteoinductivity) of the multiphasic formu-
lations might be adjusted by changing the ratios among the
phases. When compared to both a- and b-TCP, HA is a
more stable phase under the physiological conditions, as it
has a lower solubility (Table 1) and, thus, slower resorption
kinetics. Therefore, due to a higher biodegradability of the
a- or b-TCP component, the reactivity of BCP increases
with the TCP/HA ratio increasing. Thus, in vivo biore-
sorbability of BCP can be adjusted through the phase
composition. Similar conclusions are also valid for both the
biphasic TCP (in which a-TCP is a more soluble phase)
and the triphasic (HA, a-TCP and b-TCP) formulations.
Further details on this subject might be found in a topical
review (Dorozhkin 2012d).
Ion-substituted CaPO4
Last, one should very briefly mention on existence of
carbonated HA (Lafon et al. 2008; Tonegawa et al. 2010;
Yahia and Jemal 2010; Silvester et al. 2014; Fleet 2015),
chlorapatite (Kannan et al. 2007; Garcı´a-Tun˜o´n et al. 2012;
Zhao et al. 2013), as well as on a great number of CaPO4
with various ionic substitutions (CaPO4 with dopants) (Pan
and Fleet 2002; Rey et al. 2006; Kannan et al. 2008;
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Boanini et al. 2010b; Shepherd et al. 2012; Adzila et al.
2012; Grigg et al. 2014; Sˇupova´ 2015). In principle, any
ion in CaPO4 might be substituted by other ion(s). Usually,
the ion-substituted CaPO4 are of a non-stoichiometric
nature with just a partial ionic substitution and there are too
many of them to be described here. Currently, this is a hot
investigation topic; therefore, the readers are referred to the
special literature (Pan and Fleet 2002; Rey et al. 2006;
Kannan et al. 2008; Boanini et al. 2010b; Shepherd et al.
2012; Adzila et al. 2012; Grigg et al. 2014; Sˇupova´ 2015).
In addition, there is a very good review, in which the
structures of more than 75 chemically different apatites
have been discussed (White and Dong 2003).
To finalize this brief topic of ion-substituted CaPO4, it is
important to note that chemical elements not found in
natural bones can be intentionally incorporated into CaPO4
biomaterials to get special properties. For example, addi-
tion of Ag? (Pushpakanth et al. 2008; Zhang et al. 2010b;
Kim et al. 1998; Kolmas et al. 2014), Zn2? (Kim et al.
1998; Kolmas et al. 2014; Stanic´ et al. 2010) and Cu2?
(Kim et al. 1998; Kolmas et al. 2014; Stanic´ et al. 2010; Li
et al. 2010) was used for imparting antimicrobial effect,
while radioactive isotopes of 90Y (Thomas et al. 2008),
153Sm (Chinol et al. 1993; Argu¨elles et al. 1999; O’Duffy
et al. 1999) and 186Re (Chinol et al. 1993) were incorpo-
rated into HA bioceramics and injected into knee joints to
treat rheumatoid joint synovitis (Thomas et al. 2008; Chi-
nol et al. 1993; O’Duffy et al. 1999). More to the point,
apatites were found to incorporate individual molecules,
such as water, oxygen and carbon dioxide (Rey et al. 2006).
Finally, to conclude the description of the known
CaPO4, one should mention that in spite of the well-defined
crystallographic data (Table 4) and, therefore, the well-
defined shapes of the single crystals, various types of
CaPO4 can be prepared with the controllable sizes from
nano- to macro-scale (up to centimeter size) and the diverse
shapes including zero- (particles), one- (rods, fibers, wires
and whiskers), two- (sheets, disks, plates, belts, ribbons and
flakes) and three-dimensional morphologies (Sadat-Shojai
et al. 2013; Lin et al. 2014). The latter might be of versatile
morphologies and shapes (Fig. 8 is an example), including
porous and hollow structures.
Biological hard tissues of CaPO4
Biological mineralization (or biomineralization) is the
process of in vivo formation of inorganic minerals (so-
called, biominerals). One should stress that the term
‘‘biomineral’’ refers not only to a mineral produced by
organisms but also to the fact that almost all of these
mineralized products are composite materials comprised
both inorganic and bioorganic components. Furthermore,
having formed in vivo under well-controlled conditions,
the biomineral phases often have properties, such as shape,
size, crystallinity, isotopic and trace element compositions,
quite unlike its inorganically formed counterpart (please,
compare Figs. 2, 8, 10 and 15 bottom). Thus, the term
‘‘biomineral’’ reflects all this complexity (Lowenstam and
Weiner 1989).
As shown in Table 3 and discussed above, in the body of
mammals, the vast majority of both normal and pathological
calcifications consist of non-stoichiometric and ion-doped
CaPO4, mainly of apatitic structure (Pasteris et al. 2008;
Palmer et al. 2008). At the atomic scale, nano-sized crystals
bone apatite exhibit a variety of substitutions and vacancies
that make the Ca/P molar ratio distinct from the stoichio-
metric HA ratio of 1.67. Their chemical composition is
complicated and varies in relatively wide ranges. This
depends on what the animal has ingested (Grynpas et al.
1993). Occasionally, attempts are performed to compose
chemical formulas of biological apatites. For example, the
following formula Ca8.856Mg0.088Na0.292K0.010(PO4)5.312(-
HPO4)0.280(CO3)0.407(OH)0.702Cl0.078(CO3)0.050 was pro-
posed to describe the chemical composition of the inorganic
part of dental enamel (Elliott 2002).
The presence of impurities in the biological apatite of
calcified tissues introduces significant stresses into the
crystal structure, which make it less stable and more
reactive. Among all substituting ions, the presence of
4–8 % of carbonates instead of orthophosphate anions (so-
called, B-type substitution (LeGeros 1991; Elliott 1994;
Amjad 1997; Lafon et al. 2008)) and of 0.5–1.5 % of Mg is
of the special importance because it leads to large lattice
strain and significantly increases the solubility (Palmer
et al. 2008; Elliott 2002; Boskey 2006). Higher concen-
trations of Mg and carbonates in bone or dentine compared
to those in enamel (Table 3) may explain a higher solu-
bility, a lower crystallinity and smaller crystal dimensions
of bone or dentine compared to enamel.
In addition, the crystals of biological apatite are always
very small which also increases its solubility when com-
pared with that for the chemically pure HA and even
CDHA (Rey et al. 2006). However, biologic apatites of
enamel have considerably larger both crystal sizes (about
2000 nm) and crystallite dimensions compared to those of
either bone or dentine apatite. The substantial differences
in crystallite dimensions of biological apatites of different
origin are clearly seen as the well-defined X-ray diffraction
peaks of enamel apatite and much broader diffraction peaks
of either bone or dentine apatites (Fig. 9, center). Small
dimensions and a low crystallinity are two distinct features
of biological apatites, which, combined with their non-
stoichiometric composition, inner crystalline disorder and
presence of other ions in the crystal lattice, allow
explaining their special behavior. For example, the small
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crystal size means that a large percentage of the atoms are
on the surface of the crystals, providing a large specific
surface area for sorption of ions, proteins and drugs
(Boskey 2006; Vallet-Regı´ and Gonza´lez-Calbet 2004).
The major physical properties of biological apatite are
summarized in Fig. 9. It is interesting to note, that the
solubility and equilibrium phenomena of CaPO4 related to
the calcification process have been studied, at least, since
1925 (Holt et al. 1925a, b).
To the best of my findings (Dorozhkin 2012a, 2013a),
the first attempts to mimic the CaPO4 nature of bones were
performed in 1913 (Gassmann 1913). This discovery was
clarified afterwards, suggesting that the bone mineral could
be carbonated apatite (de Jong 1926; Bredig 1933). Further
optical and X-ray analysis of bones and other mineralized
tissues matched analyses of two apatites: FA and dahllite
(Taylor and Sheard 1929). Additional historical data on this
point are available in literature (Dorozhkin 2012a, 2013a).
In 1998, Weiner and Wagner wrote the following: ‘‘the
term bone refers to a family of materials, all of which are
built up of mineralized collagen fibrils’’ (Weiner and
Wagner 1998; Weiner et al. 1999). Therefore, for mam-
mals, this family of materials includes dentine—the
material that constitutes the inner layers of teeth, cemen-
tum—the thin layer that binds the roots of teeth to the jaw,
deer antlers and some other materials. It is worth noting,
that bones and teeth contain almost 99 % of the total body
calcium and about 85 % of the total body phosphorus that
amounts to a combined mass of approximately 2 kg in an
average person. In addition, it is important to recognize that
CaPO4 of bones are by no means inert; they play an
important role in the metabolic functions of the body. The
data on the physico-chemical and crystallographic study of
biological apatite are available elsewhere (Elliott 2002).
Bone
Bone, also called osseous tissue (Latin: os), is a type of
hard endoskeletal connective tissue found in many verte-
brate animals. All bones of a single animal are, collec-
tively, known as the skeleton. True bones are present in
bony fish (osteichthyes) and all tetrapods. Bones support
body structures, protect internal organs and, in conjunction
with muscles, facilitate movement (Loveridge 1999). In
addition, bones are also involved with blood cell formation,
calcium metabolism and act for mineral storage. For a
material scientist, bone is a dynamic, highly vascularized
solid tissue that is formed from a complicated biocom-
posite containing both inorganic (Table 3) and bioorganic
(chiefly, collagen) compounds, in which nanodimensional
crystals of the inorganic phases are dispersed in the meshes
of the bioorganic ones (Palmer et al. 2008; Nightingale and
Lewis 1971; Currey 2002; Rho et al. 1998; Tzaphlidou
2008). More than 20 types of collagen have been reported
in the human body, among which type I collagen is the
most abundant protein and provides much of the structural
integrity for connective tissue, particularly in bones, ten-
dons and ligaments. Furthermore, for a physiologist, bone
is a living organ populated by living cells (mainly, osteo-
blasts, osteoclasts and osteocytes); however, that is another
story. The inorganic to bioorganic ratio is approximately
75–25 % by dry weight and about 65–35 % by volume.
This ratio not only differs among animals, among bones in
the same animal and over time in the same animal but also
Fig. 9 Left crystal structure of a
biological apatite. Powder X-ray
diffraction patterns (center) and
infrared spectra (right) of
human enamel, dentine and
bone. Reprinted from Ref.
(Vallet-Regı´ and Gonza´lez-
Calbet 2004) with permission
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it exerts a major control on the material properties of bone,
such as its toughness, ultimate strength and stiffness. In
general, load-bearing ability of bones depends on not only
architectural properties, such as cortical thickness and bone
diameter, but also intrinsic, size-independent, material
properties such as porosity, level of mineralization, crystal
size and properties derived from the organic phase of bone
(Davison et al. 2006). A higher mineral to collagen ratio
typically yields stronger, but more brittle, bones (Turner
and Burr 1993; Currey 2004; Currey et al. 2004). For
example, bones from the leg of a cow have a relatively high
concentration of CaPO4 (for support), whereas bones from
the antler of a deer have a relatively high concentration of
collagen (for flexibility) (Pan and Darvell 2009a). It is
interesting to note that bones exhibit several physical
properties such as piezoelectricity (Anderson and Eriksson
1970) and pyroelectricity (Lang 1966).
Stability of the mineral composition of bones has a very
long history: CaPO4 were found in dinosaur fossils (Elorza
et al. 1999; Eagle et al. 2010; Haynes 1968; Rensberger
and Watabe 2000; Kolodny et al. 1996; Trueman and
Tuross 2002). Therefore, organisms have had a great deal
of time to exploit the feedback between composition and
structure in apatite, on the one hand, and benefit from its
biological functionality, on the other. Bones of the modern
animals are a relatively hard and lightweight porous com-
posite material, formed mostly of biological apatite (i.e.,
poorly crystalline CDHA with ionic substitutions). It has
relatively high compressive strength but poor tensile
strength (Currey and Brear 1990). While bones are essen-
tially brittle, they have a degree of significant plasticity
contributed by their bioorganic components.
The distribution of the inorganic and bioorganic phases
depends on a highly complex process that takes place
during bone formation. Each of these components may be
assembled in different proportions creating two different
architectural structures depending on the bone type and
function. They are characterized by different structural
features that strongly correlate with the mechanical per-
formance of the tissue. These two types of bones are: the
cortical bones (or compact bones) which are dense and the
cancellous bones (also known as trabecular or spongious
bones) which are less dense and less stiff than the compact
ones. Usually, bones are composed of a relatively dense
outer layer of cortical bone covering an internal mesh-like
structure (average porosity of 75–95 %) of cancellous
bone, the density of which is about 0.2 g/cm3 but it may
vary at different points (Fig. 10). Cortical bones make up a
large portion of the skeletal mass; they have a high density
(*1.80 g/cm3) and a low surface area. Cancellous bones
have an open meshwork or honeycomb-like structure. They
have a relatively high surface area but form a smaller
portion of the skeleton. Bones are a porous material with
the pore sizes ranging from 1 to 100 lm in normal cortical
bones and 200–400 lm in trabecular ones. 55–70 % of the
pores in trabecular bones are interconnected. The porosity
reduces the strength of bones but also reduces their weight
(LeGeros 1991, 2001; Lowenstam and Weiner 1989;
O’Neill 2007; Skinner 2005; Daculsi et al. 1997; Weiner
and Wagner 1998; Currey 2002; Rho et al. 1998; Rey et al.
2009; Lerebours et al. 2015).
Bones can be either woven or lamellar. The fibers of
woven bones are randomly aligned and as the result have a
low strength. In contrast, lamellar bones have parallel
fibers and are much stronger. Woven bones are put down
rapidly during growth or repair (Watt 1925) but as growth
continues, they are often replaced by lamellar bones. The
replacement process is called ‘‘secondary bone formation’’
and described in details elsewhere (Olszta et al. 2007). In
Fig. 10 General structure of a mammalian bone. Other very good
graphical sketches of the mammalian bone structure are available in
Refs. (Pasteris et al. 2008; Vallet-Regı´ and Gonza´lez-Calbet 2004)
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addition, bones might be long, short, flat, sutural, sesamoid
and irregular (Fig. 11). The sizes and shapes of bones
reflect their function. Namely, broad and flat bones, such as
scapulae, anchor large muscle masses, flat skull bones
protect the brain, ribs protect the lungs, pelvis protects
other internal organs, short tubular bones in the digits of
hands and feet provide specific grasping functions, hollow
and thick-walled tubular bones, such as femur or radius,
support weight and long bones enable locomotion (Boskey
2007; Glimcher 2006). Long bones are tubular in structure
(e.g., the tibia). The central shaft of a long bone is called
the diaphysis and has a medullar cavity filled with bone
marrow (Fig. 10). Surrounding the medullar cavity is a thin
layer of cancellous bone that also contains marrow. The
extremities of the bone are called the epiphyses and are
mostly cancellous bone covered by a relatively thin layer of
compact bone. Short bones (e.g., finger bones) have a
similar structure to long bones, except that they have no
medullar cavity. Flat bones (e.g., the skull and ribs) consist
of two layers of compact bone with a zone of cancellous
bone sandwiched between them. Irregular bones (e.g.,
vertebrae) do not conform to any of the previous forms.
Thus, bones are shaped in such a manner that strength is
provided only where it is needed. All bones contain living
cells embedded in a mineralized organic matrix that makes
up the main bone material (Boskey 2007; Glimcher 2006;
Boskey and Roy 2008). The structure of bones is most
easily understood by differentiating between seven levels
of organization because bones exhibit a strongly hierar-
chical structure (Palmer et al. 2008; Weiner and Wagner
1998; Nightingale and Lewis 1971; Currey 2002, 2005;
Rho et al. 1998; Rensberger and Watabe 2000; Cui et al.
2007; Fratzl and Weinkamer 2007; Boskey and Coleman
2010; Meyers et al. 2008; Reznikov et al. 2014a, b). One
should stress that, taking into account the presence of
ordered and disordered materials, nine hierarchical levels
for lamellar bones have been differentiated (Fig. 12;
Reznikov et al. 2014b).
The mechanical properties of bones reconcile high
stiffness and high elasticity in a manner that is not yet
possible with synthetic materials (Meyers et al. 2008).
Cortical bone specimens have been found to have tensile
strength in the range of 79–151 MPa in longitudinal
direction and 51–56 MPa in transversal direction. Bone’s
Fig. 11 Classification of bones
by shape
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elasticity is also important for its function giving the ability
to the skeleton to withstand impact. Estimates of modulus
of elasticity of bone samples are of the order of 17–20 GPa
in longitudinal direction and of 6–13 GPa in the transversal
direction (Athanasiou et al. 2000). The elastic properties of
bone were successfully modeled at the level of mineralized
collagen fibrils via step-by-step homogenization from the
staggered arrangement of collagen molecules up to an array
of parallel mineralized fibrils (Nikolov and Raabe 2008).
The investigations revealed that bone deformation was not
homogeneous but distributed between a tensile deforma-
tion of the fibrils and a shearing in the interfibrillar matrix
between them (Gupta et al. 2005; Peterlik et al. 2006).
Readers, who are interested in further details, are addressed
to a good review on the effects of the microscopic and
nano-scale structure on bone fragility (Ruppel et al. 2008).
The smallest level of the bone hierarchy consists of the
molecular components: water, biological apatite, collagen
and other proteins (Fig. 13; Duer 2015). The second
smallest hierarchical level is formed by mineralization of
collagen fibrils, which are of 80–100 nm thickness and a
length of a few to tens of microns (Fig. 12). Thus, bio-
composites of biological apatite and molecules of type I
collagen are formed (Pasteris et al. 2008; Weiner and
Wagner 1998; Nightingale and Lewis 1971; Tzaphlidou
2008; Fratzl et al. 2004). Some evidences for direct
physical bonding between the collagen fibers and apatite
crystals in bone were found (Marino and Becker 1967).
Atomic force microscopy was used to measure the crystals
of biological apatite in mature cow bones (Eppell et al.
2001). The crystals are always platelet like (elongated
along the crystallographic c-axis) and very thin (Wopenka
and Pasteris 2005; Clark and Iball 1954; Rubin et al. 2003;
Su et al. 2003), with remarkably uniform thicknesses (de-
termined in transmission electron microscopy) of 2–4 nm
(i.e., just a few unit cells thick—see Table 3). They exist in
bones not as discrete aggregates but rather as a continuous
phase, which is indirectly evidenced by a very good
strength of bones. This results in a very large surface area
facing extracellular fluids, which is critically important for
the rapid exchange of ions with these fluids. The nano-
sized crystals of biological apatite are inserted in a nearly
parallel way into the collagen fibrils, while the latter are
formed by self-assembly of collagen triple helices (Weiner
and Wagner 1998; Nightingale and Lewis 1971; Cui et al.
2007; Landis et al. 1996; Rosen et al. 2002) using the self-
organization mechanism (Sato 2006; Hartgerink et al.
2001). In addition, experimental data from electron
diffraction studies revealed that that the mineral plates of
biological apatite are not quite as ordered as previously
assumed (Olszta et al. 2007). This imperfect arrangement
of nearly parallel crystals has been supported by SAXS and
Fig. 12 A schematic illustration of the hierarchical organization of
bones. Up to level V, the hierarchical levels can be divided into the
ordered material (green) and the disordered material (blue). At level
VI, these two materials combine in lamellar bone and parallel fibered
bone. Other members of the bone family still need to be investigated
with respect to the presence of both material types; hence, they are
depicted in a box without color. Level VII depicts the lamellar
packets that make up trabecular bone material and the cylindrically
shaped lamellar bone that makes up osteonal bone. The fibrolamellar
unit comprises the primary hypercalcified layer, parallel fibered bone
and lamellar bone. c-HAP carbonated HA, GAGs glycosaminogly-
cans, NCPs non-collagenous proteins. Reprinted from Ref. (Reznikov
et al. 2014b) with permission. Other good graphical sketches of the
hierarchical structure of bones are available in Refs. (Weiner and
Wagner 1998; Cui et al. 2007; Boskey and Coleman 2010; Meyers
et al. 2008)
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transmission electron microscopy studies (Burger et al.
2008). According to the latest data, water, which always
present in bone mineral, appears to glue the mineral pla-
telets together in a way akin to how water sticks two glass
plates together—it provides firm binding between the
plates, but at the same time allows slippage between
them—flexibility for a stack of mineral platelets held
together in this way (Duer 2015).
The lowest level of hierarchical organization of bone has
successfully been simulated by CDHA precipitation on
peptide-amphiphile nanodimensional fibers (Hartgerink
et al. 2001). However, apatite platelets nucleating on the
surface of peptide tubules are not similar to the nanos-
tructure of bone and they are only an example of surface
induced nucleation (and not accurately characterized
either), while the nanostructure of bone consists of intra-
fibrillar platelets intercalated within the collagen fibrils.
However, the interface between collagen and biological
apatite is still poorly understood; for the available details,
the readers are referred to a review devoted to the structure
and mechanical quality of the collagen/mineral nanodi-
mensional biocomposite of bones (Fratzl et al. 2004).
There is still no clear idea why the crystals of biological
apatite are platelet shaped even though dahllite has
hexagonal crystal symmetry (Weiner and Wagner 1998;
Currey 2002; Rho et al. 1998; Rey et al. 2009). One pos-
sible reason is that they grow via an OCP transition phase,
in which crystals are plate-shaped (Weiner and Wagner
1998). Another explanation involves the presence of
citrates, which strongly bound to (10I¯0) surface of bio-
logical apatite because of space matching (Hu et al. 2010;
Xie and Nancollas 2010). Therefore, the crystal growth in
the [10I¯0] direction becomes inhibited, while the citrate
effect on other crystal surfaces of biological apatite appears
Fig. 13 a A schematic view of




biological apatite, consisting of
stacks of (single crystal) mineral
platelets are sandwiched into the
space between collagen fibrils.
The large platelet (100) faces
are parallel to each other and the
platelet c-axis is strongly
ordered with the collagen fibril
axis. b A schematic view of the
structure of a single mineral
platelet, with an atomically
ordered core resembling the
CDHA structure (with
substitutions) surrounded by a
surface layer of disordered,
hydrated mineral ions. c A
schematic view of the detailed
structural model of bone
mineral showing how citrate
anions and water bind the
mineral platelets together.
Reprinted from Ref. (Duer
2015) with permission
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to be very small owing to poor space matching. Thus, after
crystal growth, the (10I¯0) crystal face becomes predomi-
nant resulting in plate-like morphology of biological apa-
tite (Xie and Nancollas 2010).
The processes of bone formation (ossification) and
growth are very complicated ones and it is difficult to
describe them without making a deep invasion into biol-
ogy. It has been studied for decades (Watt 1925) but still
there are missing points. From the standpoint of chemists,
formation of bones could be considered as calcification
(i.e., deposition or precipitation of CaPO4) within the
bioorganic matrix of connective tissues (mainly cartilage),
resulting in formation of biocomposites (Palmer et al.
2008; Olszta et al. 2007). Cartilage is composed of colla-
gen fibers, cells (chondrocytes and their precursor forms
known as chondroblasts) and extracellular matrix (proteo-
glycans, which are a special class of heavily glycosylated
glycoproteins). Very briefly, the initial stage of ossification
involves synthesis and extracellular assembly of the col-
lagen matrix framework of fibrils. At the second stage,
chondrocytes calcify the matrix before undergoing the
programmed cell death (apoptosis). At this point, blood
vessels penetrate this calcified matrix, bringing in osteo-
blasts (they are mononuclear cells primarily responsible for
bone formation), which use the calcified cartilage matrix as
a template to build bone, and ions of calcium and
orthophosphate to be deposited in the ossifying tissue (Hall
2015). Therefore, the role of collagen in the nucleation,
growth, structure and orientation of apatite crystals appears
to be predominant (Wang et al. 2012). The biomineral-
ization process is controlled to some extent by cells and the
organic matrices made by those cells facilitate the depo-
sition of crystals (Boskey and Roy 2008). As bone crystals
grow, there is greater association with proteins, such as
osteocalcin, that regulate remodeling (George and Veis
2008). Thus, in vivo formation of hard tissues always
occurs by mineral reinforcement of the previously formed
network of soft tissues (Palmer et al. 2008; Olszta et al.
2007; Boskey 2007; Glimcher 2006; Cui et al. 2007).
Since the bioorganic matrix has control over the size and
orientation of CaPO4 crystals, the latter grow with a
specific crystalline orientation—the c-axes of the crystals
are roughly parallel to the long axes of the collagen fibrils
within which they are deposited (Palmer et al. 2008;
Grynpas et al. 1993; Weiner and Wagner 1998; Currey
2002; Rho et al. 1998; Tzaphlidou 2008; Olszta et al.
2007). Earlier, it was believed that this process occurred
via epitaxial growth mechanism (Marino and Becker
1970). The same was suggested for dentine and enamel
(Jodaikin et al. 1988; Fincham et al. 1995) (see ‘‘Teeth’’),
as well as for more primitive living organisms. For
example, in the shell of the fossil marine animal Lingula
brachiopod unguis that consists of a biological apatite, the
crystal c-axes are oriented parallel to the b-chitin fibrils
(Leveque et al. 2004; Williams et al. 1998; Rohanizadeh
and LeGeros 2007; Neary et al. 2011). Therefore, the ori-
entation of biological apatite crystals parallel to the long
axes of the organic framework could be a general feature of
the CaPO4 biomineralization. However, the degree of the
crystal orientation appears to be a useful parameter to
evaluate an in vivo stress distribution, a nano-scale
microstructure and a related mechanical function, a
regenerative process of the healed bone, as well as to
diagnose bone diseases such as osteoarthritis (Nakano et al.
2007, 2008). It is interesting to note that contrary to what
might be expected in accordance with possible processes of
dissolution, formation and remineralization of hard tissues,
no changes in phase composition of mineral part, crystal
sizes (length, width and thickness) and arrangement of
crystals on collagen fibers were detected in abnormal (os-
teoporotic) human bones compared to the normal ones
(Suvorova et al. 2007).
Some animals, such as newts, are able to regenerate
amputated limbs. This is, of course, of a high interest for
the regenerative medicine. Therefore, bone regeneration in
the forelimbs of mature newts was studied by noninvasive
X-ray microtomography to image regenerating limbs from
37 to 85 days. The missing limb skeletal elements were
restored in a proximal-to-distal direction, which reiterated
the developmental patterning program. However, in con-
trast to this proximal–distal sequence, the portion of the
humerus distal to the amputation site was found to fail to
ossify in synchrony with the regenerating radius and ulna.
This finding suggests that the replacement of cartilage with
mineralized bone close to the amputation site is delayed
with respect to other regenerating skeletal elements (Stock
et al. 2003).
Unlike other mineralized tissues, bone continuously
undergoes a remodeling process, as it is resorbed by spe-
cialized cells called osteoclasts and formed by another type
of cells called osteoblasts (so-called ‘‘bone lining cells’’) in
a delicate equilibrium to ensure that there are major net
changes in neither bone mass nor its mechanical strength
(Palmer et al. 2008; Olszta et al. 2007; Boskey and Roy
2008; Teitelbaum 2000; Rodan and Martin 2000). The
purpose of remodeling is the release of calcium and the
repair of micro-damaged bones from everyday stress.
Osteoblasts are mononuclear cells primarily responsible for
bone formation. They contain alkaline phosphatase, which
enzymatically produces orthophosphate anions needed for
the mineralization. In addition, there is one more type of
the cells called osteocytes that originate from osteoblasts,
which have migrated into, become trapped and surrounded
by bone matrix, which they themselves produce (Palmer
et al. 2008; Currey 2002; Olszta et al. 2007; Boskey 2007;
Glimcher 2006; Boskey and Roy 2008; Weiner et al. 2005).
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If osteoblasts are bone-forming cells, osteoclasts are
multinuclear, macrophage-like cells, which can be descri-
bed as bone-destroying cells because they mature and
migrate to discrete bone surfaces (Boskey and Roy 2008;
Teitelbaum 2000; Rodan and Martin 2000). Upon arrival,
active enzymes, such as acid phosphatase, are secreted to
produce lactic acid that causes dissolution of biological
apatite. This process, called bone resorption, allows stored
calcium to be released into systemic circulation and is an
important process in regulating calcium balance (Teitel-
baum 2000; Rodan and Martin 2000). The iteration of
remodeling events at the cellular level is influential on
shaping and sculpting the skeleton both during growth and
afterwards. That is why, mature bones always consist of a
very complex mesh of bone patches, each of which has
both a slightly different structure and a different age
(Palmer et al. 2008; Grynpas et al. 1993; Elliott 2002;
Weiner and Wagner 1998; Currey 2002; Rho et al. 1998;
Olszta et al. 2007). The interested readers are suggested to
read a review on the interaction between biomaterials and
osteoclasts (Schilling et al. 2006).
Still there is no general agreement on the chemical
mechanism of bone formation. It is clear that the inor-
ganic part of bone consists of biological apatite, i.e.,
CDHA with ionic substitutions but without the
detectable amounts of hydroxide (Rey et al. 1995a; Loong
et al. 2000; Seo et al. 2007). However, the results of
solid-state nuclear magnetic resonance on fresh-frozen
and ground whole bones of several mammalian species
revealed that the bone crystal OH- was readily detect-
able; a rough estimate yielded an OH- content of human
cortical bone of about 20 % of the amount expected in
stoichiometric HA (Cho et al. 2003). Various in vitro
experiments on precipitation of CDHA and HA revealed
that none of these compounds is directly precipitated from
supersaturated aqueous solutions containing calcium and
orthophosphate ions: some intermediate phases (precur-
sors) are always involved (LeGeros 1991, 2001; Elliott
1994; O’Neill 2007; Iijima et al. 1996; Bodier-Houlle´
et al. 1998; Rodrı´guez-Herna´ndez et al. 2005; Tomazic
et al. 1994; Nancollas and Wu 2000; Dorozhkin 2012c).
Depending on both the solution pH and crystallization
conditions, three types of CaPO4 compounds (DCPD,
ACP and OCP) have been discussed as possible precur-
sors of CDHA precipitation in vitro. Due to this reason,
the same CaPO4 are suggested as possible precursors of
biological apatite formation in vivo.
The transient nature of the precursor phase of bone, if it
exists at all, makes it very difficult to detect, especially
in vivo (Grynpas and Omelon 2007). However, in 1966
Brown proposed that OCP was the initial precipitate that
then acted as a template upon which biological apatite
nucleates (Brown 1966). This idea was extended in his
further investigations (Tung and Brown 1983, 1985; Brown
et al. 1987; Siew et al. 1992). The principal support for this
concept derived from the following: (1) the close structural
similarity of OCP and HA (Brown 1962; Brown et al.
1962); (2) formation of interlayered single crystals of OCP
and HA (pseudomorphs of OCP); (3) the easier precipita-
tion of OCP compared with HA; (4) the apparent plate- or
lath-like habit of biological apatites that does not conform
to hexagonal symmetry, but looks like a pseudomorph of
triclinic OCP; (5) the presence of HPO4
2- in bone mineral,
particularly in newly formed bones (Elliott 2002). Some
evidences supporting this idea were found using high-res-
olution transmission electron microscopy: computer-simu-
lated lattice images of the ‘‘central dark line’’ in
mineralized tissues revealed that it consisted of OCP
(Brown 1966; Bodier-Houlle´ et al. 1998; Rodrı´guez-Her-
na´ndez et al. 2005). In addition, Raman spectroscopic
indications for an OCP precursor phase were found during
intra-membranous bone formation (Crane et al. 2006).
Other evidences of OCP to HA transformation, including a
mechanistic model for the central dark line formation,
might be found in literature (Tseng et al. 2006).
Simultaneously with Brown, the research group led by
Posner proposed that ACP was the initially precipitated
phase of bone and dentine mineral formation in vivo, thus
explaining the non-stoichiometric Ca/P ratio in bones and
teeth (Eanes et al. 1965; Termine and Posner 1966a, b).
This conclusion was drawn from the following facts: (1)
when CaPO4 are prepared by rapid precipitation from
aqueous solutions containing ions of calcium and
orthophosphate at pH[ 8.5, the initial solid phase is
amorphous; (2) mature bone mineral is composed of a
mixture of ion-substituted ACP and poorly crystallized ion-
substituted CDHA; (3) early bone mineral has a lower
crystallinity than mature bone and the observed improve-
ment in crystallinity with the age of the bone mineral is a
result of a progressive reduction in the ACP content (Elliott
2002; Eanes et al. 1965; Termine and Posner 1966a, b;
Harper and Posner 1966; Posner 1969, 1973, 1978; Boskey
and Posner 1976; Glimcher et al. 1981). Interestingly,
thermodynamic data prove that the transition of freshly
precipitated ACP into CDHA involves intermediate for-
mation of OCP (Meyer and Eanes 1978a, b). However, the
discovery of a stable amorphous calcium carbonate in sea
urchin spines (Politi et al. 2004) reawakened the suggestion
that a transient amorphous phase might also exist in bones
(Olszta et al. 2007; Weiner et al. 2005, 2009; Weiner 2006;
Pekounov and Petrov 2008; Gower 2008). Afterwards,
evidences of an abundant ACP phase in the continuously
forming fin bones of zebrafish were found (Mahamid et al.
2008, 2010). The new bone mineral was found to be
delivered and deposited as packages of nanodimensional
spheres of ACP, which further transformed into platelets of
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crystalline apatite within the collagen matrix (Mahamid
et al. 2010).
Furthermore, to investigate how apatite crystals form
inside collagen fibrils, researchers carried out a time-re-
solved study starting from the earliest stages of mineral
formation (Nudelman et al. 2010). After 24 h of mineral-
ization, CaPO4 particles were found outside the fibril,
associated with the overlap region, in close proximity to
the gap zone. Cryogenic energy-dispersive X-ray spec-
troscopy confirmed that these precipitates were composed
of CaPO4, while a low-dose selected-area electron
diffraction technique showed a diffuse band characteristic
of ACP. After 48 h, CDHA crystals started to develop
within a bed of ACP and after 72 h, elongated electron-
dense crystals were abundant within the fibril, in many
cases still embedded within a less dense matrix. A low-
dose selected-area electron diffraction technique demon-
strated that the mineral phase consisted of both ACP and
oriented apatite, the latter identical to bone apatite
(Nudelman et al. 2010). This process is schematically
shown in Fig. 14 (Co¨lfen 2010). Further details on the bone
formation mechanisms are available in literature (Olszta
et al. 2007; Hall 2015; Driessens et al. 2012; Boon-
rungsiman et al. 2012), where the interested readers are
referred.
In spite of the century-plus long studies (Dorozhkin
2012a, 2013a), the maturation mechanism of bone minerals
remains to be not well established, mainly due to the dif-
ficulties involved in the nanostructural analyses (Olszta
et al. 2007; Sahar et al. 2005). Still, indirect evidences for
the in vivo bone mineral maturation are available only. For
example, X-ray diffraction patterns of bones from animals
of different age show that the reflections become sharper
with age increasing (Meneghini et al. 2003; Bilezikian
et al. 2008). This effect is more pronounced in the crys-
tallographic a-axis [(310) reflections] as compared to the c-
axis [(002) reflections] (Burnell et al. 1980; Weiner and
Traub 1986). The most comprehensive report describing
how normal human bone mineral changes in composition
and crystal size as a function of age was based on X-ray
diffraction analyses by Hanschin and Stern (Hanschin and
Stern 1995), who examined 117 homogenized iliac crest
biopsies from patients aged 0–95 years. They found that
the bone mineral crystal size and perfection increased
during the first 25–30 years and then decreased thereafter,
slightly increasing in the oldest individuals. The same 117
homogenized biopsy samples were analyzed by wave-
length-dispersive X-ray fluorescence to quantify the car-
bonate substitution in biological apatite as a function of
age. Although the changes observed in carbonate substi-
tution were relatively slight (at most 10 %), there was a
general increase from 0 to 90 years that is distinct from the
absence of a change in crystallinity after age 30 in these
samples (Boskey and Coleman 2010). In addition, other
changes, like an increase of Ca2? content and a decrease of
HPO4
2-, occur in bone mineral with age (Verdelis et al.
2007; Yerramshetty et al. 2006; Kuhn et al. 2008; Donnelly
et al. 2009; Li and Pasteris 2014; Lowenstam 1981;
Lowenstam and Weiner 1983; Plate et al. 1996; Stratmann
et al. 1996; Jahnen-Dechent et al. 1997, 2001; Schinke
et al. 1999; Savelle and Habu 2004; Chen et al. 2011b;
Delloye et al. 2007; Arau´jo et al. 2009; Koussoulakou et al.
2009; Jones 2001; Avery 2001; Nanci 2012; Xue et al.
2008; Gaft et al. 1996; Huang et al. 2007; Yin et al. 2013;
Ho et al. 2009a). Both the crystal sizes and carbonate
content were found to increase during aging in rats and
cows (LeGeros et al. 1987; Rey et al. 1995b). The increase
in carbonate content with age was also reported in other
studies (Yerramshetty et al. 2006; Kuhn et al. 2008; Don-
nelly et al. 2009; Li and Pasteris 2014). Simultaneously
with carbonate content increasing, the content of sodium
increased as well (Li and Pasteris 2014). From a chemical
point of view, these changes indicate to a slow transfor-
mation of poorly crystallized non-apatitic CaPO4 into a
better-crystallized ion-substituted carbonate-containing
CDHA. In addition, during aging, edge areas of bones were
found to become less porous, whereas the concentration of
organics in the edges was reduced (Li and Pasteris 2014).
While there are still many gaps in our knowledge, the
researchers seem to be comfortable in stating that in all but
the youngest bone and dentine, the only phase present is a
highly disordered, highly substituted biological apatite.
In general, the biomineralization process (therefore,
bone formation) can happen in two basic ways: either the
mineral phase is developed from the ambient environment
as it would from a supersaturated solution of the requisite
ions, but just requires the living system to nucleate and
localize mineral deposition, or the mineral phase is
developed under the direct regulatory control of the
organism, so that the mineral deposits are not only local-
ized but may be directed to form unique crystal habits not
normally developed by a saturated solution of the requisite
ions. In a very famous paper (Lowenstam 1981) and two
extended elaborations (Lowenstam and Weiner 1983,
1989), the first type of biomineralization was called ‘‘bio-
logically induced’’ mineralization and the second ‘‘(or-
ganic) matrix-mediated’’ biomineralization. In some
papers, the former process is called ‘‘passive’’ and the latter
one—‘‘active’’ biomineralization (Lowenstam and Weiner
1989). Briefly, an ‘‘active process’’ means an assembly of
nano-sized crystals of biological apatite into bones due to
an activity of the suitable cells (e.g., osteoblasts), i.e.,
within a matrix vesicle. Such structures have been dis-
covered by transmission electron microscopy for bone and
teeth formation (Plate et al. 1996; Stratmann et al. 1996). A
‘‘passive process’’ does not require involvement of cells
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and means mineralization from supersaturated solutions
with respect to the precipitation of biological apatite. In the
latter case, thermodynamically, biomineralization might
occur at any suitable nucleus. The collagen fibrils have a
specific structure with a 67 nm periodicity and 35–40 nm
gaps or holes between the ends of the collagen molecules
where bone mineral is incorporated in the mineralized fibril
(Weiner and Wagner 1998; Weiner et al. 1999; Tzaphlidou
2008; Boskey 2007; Glimcher 2006). Such a nucleation
within these holes would lead to discrete crystals with a
size related to the nucleating cavity in the collagen fibril
(Fig. 12). It was proposed that a temporary absence of the
specific inhibitors might regulate the process of bone for-
mation (Jahnen-Dechent et al. 1997, 2001; Schinke et al.
1999).
To conclude the bone subject, let me briefly mention on
the practical application of bones. In the Stone Age, bones
were used to manufacture art, weapons, needles, catchers,
amulets, pendants, headdresses, etc. In the coastal regions,
big bones of whales were used to construct houses (Savelle
and Habu 2004). Nowadays, cut and polished bones from a
variety of animals are sometimes used as a starting material
for jewelry and other crafts. Ground cattle bones are used
as a fertilizer (Chen et al. 2011b). Furthermore, in medi-
cine, bones are used for bone graft substitutes, such allo-
grafts from cadavers (Delloye et al. 2007) and xenografts
(Arau´jo et al. 2009). However, since recently, bone-derived
biomaterials are attempting to avoid due to serious con-
cerns about bovine spongiform encephalopathy (‘‘mad cow
disease’’) and other possible diseases that might be trans-
mitted even by heated bones.
Teeth
Teeth (singular: tooth) are dense mineralized hard tissues
found in the jaws, mouth and/or pharynx of many verte-
brates (Koussoulakou et al. 2009). They have various
structures to allow them to fulfill their different purposes.
Fig. 14 A schematic
illustration of in vivo
mineralization of a collagen
fibril: top layer—CaPO4
clusters (green) form complexes
with biopolymers (orange line),
forming stable mineral droplets;
second top layer—mineral
droplets bind to a distinct region
on the collagen fibers and enter
the fibril; second bottom layer—
once inside the collagen, the
mineral in a liquid state diffuses
through the interior of the fibril
and solidifies into a disordered
phase of ACP (black); bottom
layer—finally, directed by the
collagen, ACP is transformed
into oriented crystals of
biological apatite (yellow).
Reprinted from Ref. (Co¨lfen
2010) with permission
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The primary function of teeth is to tear and chew food,
while for carnivores it is also a weapon. Therefore, teeth
have to withstand a range of physical and chemical pro-
cesses, including compressive forces (up to *700 N),
abrasion and chemical attack due to acidic foods or prod-
ucts of bacterial metabolism (Jones 2001). The roots of
teeth are covered by gums. From the surface teeth are
covered by enamel of up to *2 mm thick at the cutting
edges of the teeth, which helps to prevent cavities on the
teeth. The biggest teeth of some gigantic animals (ele-
phants, hippopotamuses, walruses, mammoths, narwhals,
etc.) are known as tusks or ivory.
Similar to the various types of bones, there are various
types of teeth. The shape of the teeth is related to the
animal’s food, as well as its evolutionary descent. For
example, plants are hard to digest, so herbivores have many
molars for chewing. Carnivores need canines to kill and
tear and since meat is easy to digest, they can swallow
without the need for molars to chew the food well. Thus,
the following types of teeth are known: molars (used for
grinding up food), carnassials (used for slicing food),
premolars (small molars), canines (used for tearing apart
food) and incisors (used for cutting food). While humans
only have two sets of teeth, some animals have many more:
for example, sharks grow a new set of teeth every 2 weeks.
Some other animals grow just one set during the life, while
teeth of rodents grow and wear away continually through
the animal gnawing, maintaining constant length (Avery
2001; Nanci 2012).
Similar to bones, the inorganic part of teeth also consist
of biological apatite (Xue et al. 2008). The stability of the
mineral composition of teeth also has a very long history:
namely, CaPO4 were found in fossil fish teeth (Gaft et al.
1996). Similarly, investigations of biological apatite from
fossil human and animal teeth revealed its similarity to the
modem biological apatite (Huang et al. 2007). The same
was found for modern and fossil (mammoth) elephant
ivories (Yin et al. 2013).
The structure of teeth (Fig. 15 top) appears to be even
more complicated than that of bones. Unlike bones, teeth
consist of at least two different CaPO4 materials: enamel,
which is a rigid, inert and acellular outer layer, and dentine,
which is a bone-like Mg-rich hard tissue that forms the
bulk of vertebrate teeth. In addition, there is cementum,
which is a thin layer of a bone-like calcified tissue that
covers dentine at the roots of teeth and anchors them to the
jaw (Ho et al. 2009a, b; Bosshardt and Selvig 2000;
Yamamoto et al. 2010). Finally, there is the core called
pulp (commonly called ‘‘the nerve’’)—it is a remnant of the
embryologic organ for tooth development and contains
nerves and blood vessels necessary for tooth function. All
these tissues form a highly organized and complex struc-
ture (Fig. 15 top) with ideal functional and structural
capabilities, which assist in sustaining mastication-induced
mechanical loading and preventing their mechanical fail-
ures during function (Boskey 2007; Glimcher 2006; Avery
2001; Nanci 2012). It is interesting to note that the struc-
ture of teeth is common to the most species. Namely, fish,
reptiles and mammals share the same architecture of a
harder external layer and a tougher core.
Both dentine and cementum are mineralized connective
tissues with an organic matrix of collagenous proteins,
while the inorganic component of them consists of bio-
logical apatite. As shown in Table 3, dentine, cementum
and bone are quite similar and for general purposes of
material scientists they are regarded as being essentially the
same material (Elliott 2002; Weiner and Wagner 1998;
Currey 2002; Rho et al. 1998; Fratzl et al. 2004; Rubin
et al. 2003; Su et al. 2003; Pellegrino and Blitz 1972;
LeGeros et al. 1987; Jones 2001). However, strictly
speaking, there are some differences among them. For
example, the hardness of live dentine is less than that of
Fig. 15 Top a schematic drawing of a tooth. Other very good
graphical sketches of the mammalian tooth structure, including the
hierarchical levels, are available in Refs. (Palmer et al. 2008; Meyers
et al. 2008). Bottom a scanning electron micrograph of the forming
enamel of a continuously growing rat incisor showing ordered rods of
CaPO4. Scale bar 10 lm. Reprinted from Ref. (Lowenstam and
Weiner 1989) with permission
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enamel but is greater than that of bone or cementum (Ho
et al. 2009a). When pulp of the tooth dies or is removed by
a dentist, the properties of dentine change: it becomes
brittle, liable to fracture and looses a reparative capability.
In addition, unlike bones, both dentine and cementum lack
vascularization. In spite of these minor differences, let us
consider that the majority of the statements made in the
previous section for bones are also valid for dentine and
cementum.
Dental enamel is the outermost layer of teeth. It is
white and translucent and its true color might be observed
at the cutting edges of the teeth only. Enamel is highly
mineralized and acellular, so it is not a living tissue.
Nevertheless, it is sufficiently porous for diffusion and
chemical reactions to occur within its structure, particu-
larly acidic dissolution (dental caries) and remineraliza-
tion from saliva (possible healing of caries lesions).
Therefore, it acts as a selectively permeable membrane,
allowing water and certain ions to pass via osmosis
(Avery 2001; Nanci 2012).
Enamel is the hardest substance in the body and forms a
solid, tough and wear-resistant surface for malaxation
(Chai et al. 2009). In the mature state, it contains up to
98 % of inorganic phase (Table 3). Other components of
enamel include remnants of the organic matrix and loosely
bound water molecules. Interestingly, from the mechanical
point of view, dental enamel was found to be a ‘‘metallic-
like’’ deformable biocomposite, because enamel was found
to have a similar stress–strain response to that of cast alloy
and gold alloy, all of which showed work-hardening effect
(He and Swain 2007). The crystals of biological apatite of
enamel are much larger as evidenced by higher crystallinity
(reflecting greater crystal size and perfection) demonstrated
in their X-ray diffraction patterns than those of bone and
dentine. Besides, enamel apatite has fewer ionic substitu-
tions than bone or dentine mineral and more closely
approximates the stoichiometric HA (Boskey 2007). The
organic phase of enamel does not contain collagen. Instead,
enamel has two unique classes of proteins called amelo-
genins and enamelins. While the role of these proteins is
not fully understood yet, it is believed that both classes of
proteins aid in the enamel development by serving as a
framework support (Avery 2001; Nanci 2012; Margolis
et al. 2006). The large amount of minerals in enamel
accounts not only for its strength but also for its brittleness.
Dentine, which is less mineralized and less brittle, com-
pensates for enamel and is necessary as a support (Avery
2001; Nanci 2012). Shark enameloid is an intermediate
form bridging enamel and dentine. It has enamel-like
crystals of fluoridated biological apatite associated with
collagen fibrils (Lowenstam and Weiner 1989; Rey et al.
2006; Prostak et al. 1993; Dahm and Risnes 1999; Carr
et al. 2006; Enax et al. 2014). Due to the presence of
fluorides, biological apatite of shark enameloid shows both
higher crystal sizes and a more regular hexagonal sym-
metry if compared to non-fluoridated biological apatite of
bones and teeth (Daculsi et al. 1997). Similar correlation
between the presence of fluorides and crystal dimensions
was found for enamel (Vieira et al. 2003).
Like that for bones, seven levels of structural hierarchy
have been also discovered in human enamel; moreover, the
analysis of the enamel and bone hierarchical structure
suggests similarities of the scale distribution at each level
(Palmer et al. 2008; Athanasiou et al. 2000; Cui and Ge
2007). On the mesoscale level, there are three main
structural components: a rod, an interrod and aprismatic
enamel. Among them, the enamel rod (formerly called an
enamel prism) is the basic unit of enamel. It is a tightly
packed mass of biological apatite in an organized pattern.
Each rod traverses uninterrupted through the thickness of
enamel. They number 5–12 million rods per crown. The
rods increase in diameter (4 up to 8 microns) as they flare
outward from the dentine-enamel junction (DEJ). Needle-
like enamel rods might be tens of microns long (up to
100 lm) but sometimes only 50 nm wide and 30 nm thick
(Fig. 15 bottom; Avery 2001; Nanci 2012; Jandt 2006;
Chen et al. 2004; Ro¨nnholm 1962; Nylen et al. 1963;
Miake et al. 1993; Daculsi et al. 1984; Jodaikin et al. 1984;
Bres and Hutchison 2002). They are quite different from
the much smaller crystals of dentine and bone (Table 3),
but all of them consist of biological apatite (Schroeder and
Frank 1985; Bre`s et al. 1990). In cross section, an enamel
rod is best compared to a keyhole, with the top, or head,
oriented toward the crown of the tooth and the bottom, or
tail, oriented toward the root of the tooth.
The arrangement of the crystals of biological apatite
within each enamel rod is highly complex. Enamel crystals
in the head of the enamel rod are oriented parallel to the
long axis of the rod. When found in the tail of the enamel
rod, the crystals’ orientation diverges slightly from the long
axis (Avery 2001; Nanci 2012). The arrangement of the
enamel rods is understood more clearly than their internal
structure. Enamel rods are found in rows along the tooth
(Fig. 15 bottom) and, within each row, the long axis of the
enamel rod is generally perpendicular to the underlying
dentine (Avery 2001; Nanci 2012; Jandt 2006; Chen et al.
2004; Ro¨nnholm 1962; Nylen et al. 1963; Miake et al.
1993). An AFM study indicated that apatite crystals in
enamel exhibited regular sub-domains or subunits with
distinct chemical properties related to topographical fea-
tures and gave rise to patterned behavior in terms of the
crystal surface itself and the manner in which it responded
to low pH (Robinson et al. 2004). In addition, the results of
the investigations of human single apatite crystals of both
enamel and dentine revealed an absence of the mirror plane
perpendicular to the c-axis leading to the P63 space group
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(Mugnaioli et al. 2014) instead of the P63/m space group
typical for HA and FA (Table 4).
The second structural component of the enamel matrix is
the interrod (or interprismatic) enamel, which surrounds
and packs between the rods. The difference between the
rod and the interrod is the orientation of apatite crystals;
the rod contains aligned crystallites, whereas the mineral in
the interrod is less ordered. These structures coalesce to
form the tough tissue of enamel, which can withstand high
forces and resist damage by crack deflection. The third
structure, aprismatic enamel, refers to the structures con-
taining apatite crystals that show no meso-scale or macro-
scale alignment (Palmer et al. 2008).
The in vivo formation and development of teeth appears
to be even more complicated when compared with the
aforedescribed process of bone formation. It is a very
complex biological process, by which teeth are formed
from embryonic cells, grow and erupt into the mouth
(Boskey and Roy 2008). For human teeth enamel, dentine
and cementum must all be developed during the appro-
priate stages of fetal development. Primary (baby) teeth
start to form between the sixth and eighth weeks in utero,
while the permanent teeth begin to form in the twentieth
week in utero (Avery 2001; Nanci 2012). Experimental
data confirmed the necessity of CaPO4 in the diet of
pregnant and nursing mother to prevent early childhood
dental caries (Warf and Watson 2008).
As teeth consist of at least two materials with different
properties (enamel and dentine), the tooth bud (sometimes
called ‘‘the tooth germ’’—that is an aggregation of cells
that eventually forms a tooth) is organized into three parts:
the enamel organ, the dental papilla and the dental follicle.
The enamel organ is composed of at least four other groups
of cells [for the biological details see Refs. (Avery 2001;
Nanci 2012)]. Altogether, these groups of cells give rise to
ameloblasts, which secret enamel matrix proteins. The
protein gel adjacent to ameloblasts is supersaturated with
CaPO4, which leads to the precipitation of biological
apatite. Similarly, the dental papilla contains cells that
develop into odontoblasts, which are dentine-forming cells.
The dental follicle gives rise to three important entities:
cementoblasts, osteoblasts and fibroblasts. Cementoblasts
form the cementum of a tooth (Bosshardt and Selvig 2000).
Osteoblasts give rise to the alveolar bone around the roots
of teeth (see bone formation above). Fibroblasts develop
the periodontal ligaments that connect teeth to the alveolar
bone through cementum (Boskey 2007; Glimcher 2006;
Boskey and Roy 2008; Hall 2015; Avery 2001; Nanci
2012).
The first detectable crystals in enamel formation are flat
thin ribbons (Ro¨nnholm 1962; Nylen et al. 1963; Miake
et al. 1993) that were reported to be OCP (Brown and
Chow 1976; Simmer and Fincham 1995; Diekwisch et al.
1995; Aoba 1996), b-(Ca,Mg)3(PO4)2 (Diekwisch et al.
1995), DCPD (Rey et al. 1995a; Bonar et al. 1991) or ACP
(Beniash et al. 2009). The formation process of enamel is
different from that for bone or dentine: amelogenin being
hydrophobic self-assembles into nano-sized spheres that
guide the growth of the ribbon-like dental enamel crystals.
During maturation of enamel, the mineral content increases
from initially *45 wt.% up to *98–99 wt.% (Avery
2001; Nanci 2012; Bonar et al. 1991). The enamel crystal
rods widen and thicken by additional growth (Rey et al.
1995b; Bonar et al. 1991; Smith 1998) with a simultaneous
increase of the Ca/P molar ratio (Smith 1998) and a
decrease in carbonate content (Sydney-Zax et al. 1991; Rey
et al. 1991; Takagi et al. 1998), finally resulting in the most
highly mineralized and hardest substance produced by
vertebrates. It is interesting to note that in the radular teeth
of chitons, ACP was found to be the first-formed CaPO4
mineral, which over a period of weeks was transformed to
dahllite (Lowenstam and Weiner 1985).
The crystal faces expressed in enamel are always (100)
face and at the ends presumably (001) (Selvig 1970, 1973),
which are the ones usually found in HA. The centers of
enamel crystals contain a linear structure known as the
‘‘central dark line’’ (this line was also observed in bone and
dentine), which consists of OCP (Iijima et al. 1996; Bodier-
Houlle´ et al. 1998; Rodrı´guez-Herna´ndez et al. 2005;
Tseng et al. 2006). However, data are available that the
‘‘central dark line’’ appears to be the calcium richest part of
the human tooth enamel crystallites (Gasga et al. 2008). As
described above for bones, X-ray diffraction studies
revealed that the biological apatite of younger teeth was
less crystalline than that of more mature ones, while the
maximum crystallinity was found for teeth belonged to
people of 31–40 years old (Pankaew et al. 2012). There-
fore, maturation of teeth also means a slow transformation
(re-crystallization?) of biological CaPO4 from ion-substi-
tuted ACP to a better-crystallized ion-substituted CDHA.
However, crystallinity of teeth belonged to older people
(41–50 and 51–60 years old) was found to decrease with
age. Simultaneously, thermogravimetric studies revealed
bigger weight loss for teeth of the older people (Pankaew
et al. 2012), which could be due to a greater amount of
carbonates.
The development of individual enamel and dentine
crystals was studied by high-resolution transmission elec-
tron microscopy. Both processes appear to be roughly
comparable and were described in a four-step process. The
first two steps include the initial nucleation and formation
of nano-sized particles of biological apatite. They are fol-
lowed by ribbon-like crystal formation, which until
recently was considered as the first step of biological
crystal formation (Cuisinier et al. 1993; Houlle´ et al. 1997).
These complicated processes, starting with the
Prog Biomater (2016) 5:9–70 39
123
heterogeneous nucleation of inorganic CaPO4 on an
organic extracellular matrix, are controlled in both tissues
by the organic matrix and are under cellular control
(Bodier-Houlle´ et al. 1998; Mann 1993). To complicate the
process even further, regular and discrete domains of var-
ious charges or charge densities on the surface of apatite
crystals derived from the maturation stage of enamel
development were discovered by a combination of atomic
and chemical force microscopy (Kirkham et al. 2000).
Binding of organic molecules (e.g., amelogenin (Kirkham
et al. 2000)) at physiological solution pH appears to occur
on the charged surface domains of apatite. The recent
visions on dental tissue research are available elsewhere
(Smith and Tafforeau 2008).
As teeth consist of several materials, there are mutual
junctions among them. For example, a dentine–enamel
junction (DEJ) is a thin [2.0 ± 1.1 lm (Habelitz et al.
2001)] but gradual interface with characteristics transiting
from those of dentine to those of enamel. Namely, the
collagen fibers in dentine were found to enter into the
enamel side of DEJ and terminate in a region in which
crystals of biological apatite begin to show enamel char-
acteristics (Chan et al. 2011). In addition, the average
contents of organic matrix and carbonate ions were found
to increase in the order: enamel\DEJ\ dentin. Further-
more, HPO4
2- ions were not detected in the DEJ, while in
dentin their content was higher than in enamel (Kolmas
et al. 2010). Comparable results were obtained in another
study (Desoutter et al. 2014). Besides, both chemical and
molecular structure of DEJ appeared to be dependent on
the intratooth location (Xu et al. 2009). Genetically, it is a
remnant of the onset of enamel formation because enamel
grows outwards from this junction (Nanci 2012).
Mechanically, DEJ plays an important role in preventing
crack propagation from enamel into dentine (Imbeni et al.
2005). Hierarchically, DEJ has a three-level structure:
25–100 lm scallops with their convexities directed toward
the dentin and concavities toward the enamel, 2–5 lm
microscallops and a smaller scale structure (Marshall et al.
2003). Therefore, high-resolution elastic modulus mapping
has indicated that the DEJ is a band with a graded
mechanical property rather than a discrete interface (Sui
et al. 2014). The major steps of enamel crystal growth at
the junction have been described above but the mechanism
of the junction formation is still debatable. Some authors
claim that enamel crystals grow epitaxially on the pre-
existing dentine crystals because of a high continuity
between enamel and dentine crystals (Arsenault and
Robinson 1989; Hayashi 1992, 1993). Others have shown
that enamel crystals are formed at a given distance from the
dentine surface (Simmer and Fincham 1995; Diekwisch
et al. 1995; Aoba 1996; Bodier-Houlle´ et al. 2000) and
could either reach dentine crystals by a subsequent growth
(Takano et al. 1996) or remain distant (Bodier-Houlle´ et al.
2000; Dong and Warshawsky 1996). In addition, there are
both a cementum–enamel junction (CEJ) (Wang et al.
2006b), which is quite similar to DEJ, and a cementum–
dentine junction (CDJ) (Ho et al. 2004, 2005; Jang et al.
2014).
Enamel formation, or amelogenesis, is a highly regu-
lated process involving precise genetic control as well as
protein–protein interactions, protein–mineral interactions
and interactions involving the cell membrane. Much is still
unknown about the interactions among proteins present in
enamel matrix and the final crystalline phase of biological
apatite (Palmer et al. 2008; Paine et al. 2001). At some
point before a tooth erupts into the mouth, the ameloblasts
are broken down. Consequently, unlike bones, enamel has
no way to regenerate itself using the process of ‘‘active
mineralization’’ (see bone formation) because there is no
biological process that repairs degraded or damaged
enamel (Avery 2001; Nanci 2012). In addition, certain
bacteria in the mouth feed on the remains of foods, espe-
cially sugars. They produce lactic acid, which dissolves the
biological apatite of enamel in a process known as enamel
demineralization that takes place below the critical pH of
about 5.5. Similar process called enamel erosion occurs
when a person consumes acid-containing (citric, lactic,
phosphoric, etc.) soft drinks (Jandt 2006; Barbour and Rees
2004; Low and Alhuthali 2008; White et al. 2010). Evi-
dences exist that there is a preferential loss of carbonates
and Mg during acidic dissolution of mineral in dental
caries. Luckily, saliva gradually neutralizes the acids that
cause pH on teeth surface to rise above the critical pH. This
might cause partial enamel remineralization, i.e., a return
of the dissolved CaPO4 to the enamel surface. Until
recently, it was generally agreed that if there was sufficient
time between the intake of foods (generally, 2–3 h) plus a
damage was very limited, teeth could repair themselves by
the ‘‘passive mineralization’’ process (LeGeros 1999). Data
on increased remineralization of dental enamel by CaPO4-
containing compounds (Cochrane et al. 2008; Langhorst
et al. 2009; Weir et al. 2012) are in support of this
hypothesis.
However, studies performed using atomic force micro-
scopy nano-indentation technique revealed that previously
demineralized samples of dental enamel further exposed to
remineralizing solutions did show a dense crystalline layer
of CaPO4 formed on their surface. Unfortunately, the re-
precipitated deposits of CaPO4 always consisted of loosely
packed crystals and did not protect the underlying enamel
from a subsequent acid attack. Furthermore, these surface
deposits were completely removed by either a toothbrush
or a short exposure to an erosive acidic solution (Jandt
2006; Lippert et al. 2004a, b, c). In this context, it should
be emphasized that the term ‘‘remineralization’’, which is
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often misused in the literature, should imply the process of
mineral growth that goes hand in hand with a strengthening
effect of the weakened enamel surface. Since no
strengthening of an exposure to remineralizing solutions
was observed, it might be considered that no ‘‘passive
mineralization’’ was found (in spite of the real evidence of
the re-precipitated surface deposits of CaPO4) (Jandt 2006;
Lippert et al. 2004b, c).
An interesting hypothesis that nano-sized apatite crys-
tallites occur in the oral cavity during extensive physio-
logical wear of the hierarchical structured enamel surface
due to dental abrasion and attrition has been published
(Hannig and Hannig 2010). These nano-scaled apatite
enamel crystallites might promote remineralization at the
tooth surface. However, this idea should be verified
experimentally. Thus, according to the current knowledge,
the enamel self-repairing ability by a passive remineral-
ization appears to be doubtful, while an active remineral-
ization is impossible. Nevertheless, investigations in this
field keep going (Karlinsey and Mackey 2009; Karlinsey
et al. 2010a, b; Busch 2004; Onuma et al. 2005; He and
Feng 2007; Li et al. 2008b, 2014a; Wang et al. 2009;
Roveri et al. 2009a, b; Peters et al. 2010; Orsini et al. 2010;
Uysal et al. 2010; Niu et al. 2014). For example, ACP-
containing orthodontic biocomposite resins might reduce
the enamel decalcification found in patients with poor oral
hygiene (Uysal et al. 2010). Further details on CaPO4
application in dentistry are available in a topical review
(Dorozhkin 2013c).
A content of fluoride added to either toothpaste or
mouthwash lowers the solubility of CaPO4 (by formation
of FHA on the surface) and therefore improves the acid
resistance of dental enamel (Schemehorn et al. 2011;
Hattab 2013; Driessens 1973; Moreno et al. 1974;
McClendon 1966). Furthermore, fluorides also reduce
production of acids by bacteria in the mouth by reducing
their ability to metabolize sugars. However, dental treat-
ment by fluorides must be used with care because an
improper treatment results in formation of CaF2 globules
deposited on the enamel surface (Wang et al. 2008a).
To conclude the teeth subject, let me briefly mention
on the practical application of teeth. Due to relatively
small dimensions of normal teeth, only tusks and ivory
of giant animals are widely used. For example, both the
Greek and Roman civilizations used large quantities of
ivory to make high value works of art, precious religious
objects and decorative boxes for costly objects. Ivory
was often used to form the whites of the eyes of statues.
Prior to introduction of plastics, it was used for billiard
balls, piano keys, buttons and ornamental items. The
examples of modern carved ivory objects are small
statuary, netsukes, jewelry, flatware handles and furniture
inlays.
Antlers
Deer antlers (Fig. 16 top) are unique biological structures
since their growth rate is without parallel in vertebrates and
because they are the only bony appendages in mammals
capable of complete regeneration. This allows for basic
research in bone biology without the interference of sur-
gical procedures and their adverse effects in animals where
samples are obtained. In addition, antlers also allow for the
gathering of a large amount of samples from different
populations to assess nutritional and ecological effects on
bone composition and structure (Yue et al. 2005; Zhao
et al. 2006; Landete-Castilleijos et al. 2007a). They are
costly sexual secondary characters of male deer and con-
stitute 1–5 % of the body weight (Huxley 1931). Recent
studies suggest that antler regeneration is a stem cell-based
process and that these stem cells are located in the pedicle
periosteum (Kierdorf et al. 2009; Kierdorf and Kierdorf
2011).
Antlers are not true horns; they are a simple extension of
bone. Both antlers and bones utilize the same basic
building blocks, namely the type I collagen in the protein
phase and the carbonated CDHA in the mineral phase,
which was verified by amino acid analysis, X-ray diffrac-
tion and TEM observations (Chen et al. 2009). Antlers are
large and complex horn-like appendages of deer consisting
of bony outgrowths from the head with no covering of
keratin as found in true horns. Usually, they begin growing
in March and reach maturity in August. In winter, antlers
fall off; this is known as shedding. Similar to bones, antlers
contain pores and can withstand applied stresses of over
300 MPa (Landete-Castilleijos et al. 2007b; Evans et al.
2005; Akhtar et al. 2008; Currey et al. 2009), which is even
higher than that of bones (Table 3). Therefore, antlers are
occasionally considered an almost unbreakable bone
(Currey et al. 2004). However, there are several distinct
differences between them. Namely, antlers and skeletal
bones have different functions. The primary functions of
antlers are social display, defense against predators and
combat between male species. Skeletal bones contain bone
marrow, whereas antlers have no marrow. There exists a
transition zone between cortical and cancellous bones in
antlers, whereas there is no such transition zone in skeletal
bones. The cancellous bone is well aligned and uniformly
distributed through the entire antler. In bovine femur, the
cancellous bone is mainly located in the femur head and its
density decreases progressively toward the central region
of the femur, which correlates to the external loading
conditions. In addition, antlers have a lower mineral con-
tent and consequently lowest elastic modulus among min-
eralized calcified tissues with a mineral content of
*50 wt% (or *30 vol. %). Interesting that antlers may
act as large hearing aids; namely, moose with antlers have
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far more sensitive hearing than moose without them
(Bubenik and Bubenik 2008).
Since antlers are accessible, shed after mating season
and cast every year, they appear to be a good model to
study bone biology (Price et al. 2005; Landete-Castilleijos
et al. 2007c; Li et al. 2014b). Each antler grows from an
attachment point on the skull called a pedicle. While an
antler is growing, it is covered with highly vascular skin
called velvet, which supplies oxygen and nutrients to the
growing bone. Antlers bud and branch as they grow. Once
they have achieved the proper dimensions, the velvet starts
to dry out, cracks and breaks off, while the antler’s bone
dies. Therefore, fully developed antlers consist of dead
bone only (Kierdorf and Kierdorf 2000, 2005; Pathak et al.
2001; Yuxia et al. 2002; Li et al. 2005). However, the
formation and mineralization process of antlers is still not
fully understood. To clarify this, researchers used oxyte-
tracycline injections to label different stages of bone for-
mation in antlers of 14 red deer between days 28 and 156 of
antler growth. The results revealed that initially a trabec-
ular scaffold of woven bone was formed which largely
replaced a pre-existing scaffold of mineralized cartilage.
Lamellar bone was then deposited and from about day 70
onwards, primary osteons filled in the longitudinal tubes
lined by the scaffold in a proximal to distal sequence
(Gomez et al. 2013). In addition, it was found that food
processing cannot supply the mineral needs required for
antler growth and thus, male deer must temporarily resorb
CaPO4 minerals from their own skeleton for antler growth
(Meister 1956; Muir et al. 1987; Baxter et al. 1999).
Detailed studies revealed that daily food intake provided
between 25 and 40 % of calcium needed for antler min-
eralization, which resulted in a temporary skeleton dem-
ineralization (Muir et al. 1987; Baxter et al. 1999).
One should note that people seldom come across the
antlers in the woods. Rabbits and rodents such as mice and
chipmunks eat antlers (and bones of wild animals after they
die) for calcium. Rodents and rabbits also gnaw bones and
antlers to sharpen their incisors. Due to an extremely high
growth rate, which can achieve 2–4 cm per day, combined
with a very fast biomineralization, these unique appen-
dages might be a well-suited animal model for studying the
disturbances of bone formation induced by additives (e.g.,
by excess of fluoride) (Kierdorf and Kierdorf 2005). Antler
size and external characteristics were found to be influ-
enced by nutrition, climatic variability and other factors.
Thus, since antlers are periodically replaced, the analysis of
naturally cast antlers offers the opportunity for a continu-
ous and a noninvasive monitoring of the environmental
pollution by these additives (Kierdorf and Kierdorf 2005).
To conclude this part, let me briefly mention on the
practical application of antlers. Associated with aristoc-
racy, antlers have adorned European castles and hunting
lodges for centuries. Today, furnishings and accessories
made from antlers are featured in fine homes throughout
the world and are a reflection of grace and elegance
(Fig. 16 bottom). Concerning biomedical applications, the
initial attempts to evaluate a potential use of deer antlers as
xenogenic bone grafts have been already performed
(Baciut et al. 2007; Hasan et al. 2012; Zhang et al. 2012,
2013).
Fig. 16 Top red deer stag at velvet shedding. The bare bone of the
hard antlers is exposed. Reprinted from Ref. (Kierdorf and Kierdorf
2011) with permission. A good cross-sectional image of a deer antler
is available in Ref. (Meyers et al. 2008). Bottom fallen antlers used to
make a chandelier
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Pathological calcification of CaPO4
In the body of mammals, osteoblasts and odontoblasts fix
ions of calcium and orthophosphate and then precipitate
biological apatite onto an organic matrix. This is the pro-
cess of physiological biomineralization that is restricted to
the specific sites in skeletal tissues, including growth plate
cartilage, bones, teeth and antlers (Lowenstam and Weiner
1989; Daculsi et al. 1997). Normally, mammals are sup-
posed to die with CaPO4 located in bones and teeth (and
antlers for male deer) only and nowhere else, because
under the normal conditions soft tissues are not mineral-
ized. Unfortunately, owing to aging, various diseases and
under certain pathological conditions blood vessels, mus-
cles, extracellular matrix of articular cartilaginous tissues
of the joints and some internal organs are calcified as well.
This process is called pathological calcification or ectopic
(bio)mineralization and leads to a morbidity and a mor-
tality (Lowenstam and Weiner 1989; Daculsi et al. 1997;
Block et al. 1998). In general, any type of abnormal
accumulation of CaPO4 in wrong places is accounted for
by a disruption of systemic defense mechanism against
calcification (Kazama et al. 2006).
To the best of my findings (Dorozhkin 2012a, 2013a),
the earliest paper on a negative influence of unwanted
depositions of CaPO4 in the body was published as early as
in 1798 (Pearson 1798). According to the data available
(Poloni and Ward 2014), the unwanted depositions could
consist of many substances and all of them always lead to
various diseases. Regarding the unwanted depositions of
CaPO4, they are found in soft tissue calcification (in
damaged joints, blood vessels, dysfunctional areas in the
brain, diseased organs, scleroderma, prostate stones) (Reid
and Andersen 1993; Scotchford and Ali 1995; P’ng et al.
2008; Brancaccio and Cozzolino 2005; Goff and Reichard
2006; Bittmann et al. 2003; Molloy and McCarthy 2006;
Giachelli 2004; Kazama et al. 2007), kidney (Giannossi
and Summa 2012; Mukherjee 2014) and urinary (Zhu et al.
2014; Huo et al. 2015; Selvaraju et al. 2015) stones, dental
pulp stones and dental calculus (Kakei et al. 2009; Kodaka
et al. 1988, 1998; C¸iftc¸ioglu et al. 1998; Hayashizaki et al.
2008), salivary stones (Zelentsov et al. 2001; Luers et al.
2014), gall stones (Qiao et al. 2013; Hussain and Al-
Jashamy 2013), pineal gland calcifications (Gu¨ney et al.
2013), atherosclerotic arteries and veins (Ortlepp et al.
2004; Tomazic 2001; Marra et al. 2006; Kurabayashi
2013), coronary calcification (Fitzpatrick et al. 2003;
Matsui et al. 2015), damaged cardiac valves (Suvorova and
Buffat 2005), calcification on artificial heart valves (Gi-
achelli 2001; Pettenazzo et al. 2001; Schoen and Levy
2005; Delogne et al. 2007), carpal tunnel (Sensui et al.
2003; Namba et al. 2008) and tumoral (Namba et al. 2008;
Carlson et al. 2007; Sprecher 2010; Slavin et al. 2012; Kim
et al. 2013; Burns et al. 2013) calcifications, cataracts (Kim
and Choi 2007; Koinzer et al. 2009), malacoplakia (Ho
1989), calcified menisci (Katsamenis et al. 2012; Des-
sombz et al. 2013), dermatomyositis (Stock et al. 2004;
Pachman and Boskey 2006) and still other places (Daculsi
et al. 1997; Bazin et al. 2014b). In addition, there is a
metastatic calcification of non-osseous viable tissue
occurring throughout the body (Hale 2003; Alkan et al.
2009), but it primarily affects the interstitial tissue of the
blood vessels, kidney, lungs and gastric mucosa. A meta-
static calcification is defined as a deposition of CaPO4 in
previously normal tissue due to an abnormal biochemistry
with disturbances in the calcium or phosphorus metabolism
(Grech et al. 1998). Common causes of the metastatic
calcification include hyperparathyroidism, chronic renal
disease, massive bone destruction in widespread bone
metastases and increased intestinal calcium absorption.
One author has mentioned on ‘‘apatite diseases’’ which are
characterized by the appearance of needle-like crystals
comparable to those of bone apatite in the fibrous con-
nective tissue (Mohr 2003). All these cases are examples of
a calcinosis (Sprecher 2010; Slavin et al. 2012; Kim et al.
2013; Burns et al. 2013), which might be described as a
formation of undesired CaPO4 deposits in any soft tissue.
In dentistry, a calculus or a tartar refers to a hardened
plaque on the teeth, formed by the presence of saliva,
debris and minerals (White 1997). Its rough surface pro-
vides the ideal medium for bacterial growth, threatening
the health of the gums and absorbing unaesthetic stains far
more easily than natural teeth (LeGeros 1991).
Calcifying nanodimensional particles are the first
CaPO4-containing particles isolated from human blood and
were detected in numerous pathologic calcification related
diseases (Ciftc¸iog˘lu and McKay 2010). Interestingly, con-
trary to the mineral phases of normal calcifications (bone,
dentine, enamel, cementum, antlers), which consist of only
one type of CaPO4 (namely, biological apatite), the mineral
phases of abnormal and/or pathological calcifications are
found to occur as single or mixed phases of other types of
CaPO4 (ACP, DCPD, OCP, b-(Ca,Mg)3(PO4)2) and/or
other phosphate and non-phosphate compounds (e.g.,
magnesium orthophosphates, calcium pyrophosphates,
calcium oxalates, etc.) in addition to or in place of bio-
logical apatite (Table 5; LeGeros 1991, 2001; Amjad 1997;
Daculsi et al. 1997; Qiu and Orme 2008; Kodaka et al.
1988; Reid and Andersen 1993; Scotchford and Ali 1995;
P’ng et al. 2008; Bazin et al. 2014b; Lee et al. 2006;
Rosenthal 2007; Lagier and Baud 2003; Wesson and Ward
2007). However, precipitation of biological apatite in
wrong places is also possible; this is the so-called ‘‘HA
deposition disease’’ (Burns et al. 2013; Hayes and Conway
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1990; Best et al. 1997; Garcia et al. 2003; Melrose et al.
2009).
Occurrence of non-apatite phases in the pathological
calcifications may indicate that they were crystallized
under the conditions different from homeostasis or crys-
tallization of the apatite structures was inhibited and less
stable phases crystallized instead, without further change to
the more stable one. Furthermore, in the places of patho-
logical calcifications the solution pH is often relatively
low. Given that nucleation and crystal growth is not a
highly regulated process in any pathological deposits, there
is not likely just one fundamental formation mechanism for
all possible calcification types. Furthermore, various
bioorganic impurities in the local environment undoubtedly
influence the crystallization process, resulting in a great
variety of pathological deposits. Thus, it is a highly com-
plex problem. In some cases, the chemical composition of
an unwanted inorganic phase might depend on the age of
the pathological calcification and its location. For example,
DCPD is more frequently found in young (3 months or
younger) calculus, biological apatite is present in all ages
of calculus, while b-(Ca,Mg)3(PO4)2 occurs more fre-
quently in sub-gingival calculus. In mature calculus, the
relative abundance of OCP, b-(Ca,Mg)3(PO4)2 and bio-
logical apatite also differ between the inner and outer
layers (LeGeros 2001). It is interesting to note that the
mineral phases of animal calculus (e.g., from dog) was
found to consist of calcium carbonate and biological apa-
tite, while human calculi do not contain calcium carbonate
(LeGeros 2001; LeGeros et al. 1988).
The nucleation process is the main step in both normal
and pathological calcifications. In vitro experiments per-
formed to simulate the formation of sedimentary urinary
stones demonstrated that in the absence of organic matter
no CaPO4 crystallized in cavities with scarce liquid reno-
vation, but regular CDHA layers appeared on the wall
around the cavity (Grases and Llobera 1998). Visible
deposits of calcified organic materials (mixtures of organic
matter and spherulites of CDHA) were formed when a
glycoprotein (mucin) was present. In this case, the walls of
the cavity as well as the glycoproteins had the capacity to
act as heterogeneous nucleators of CaPO4. CDHA micro-
crystal nucleation on the surface of epithelial cells can be a
critical step in the formation of kidney stones (Lieske et al.
1997) and identical mechanisms can be thought for
unwanted calcifications in other soft tissues of the body,
such as cardiac valves or vascular ducts. Monolayers of
CDHA crystals can bind to epithelial cells. A large amount
of kidney stones contains CDHA as the crystallization
nuclei.
In general, formation of crystals in pathological miner-
alizations follows the same principles as normal calcifica-
tions (Kirsch 2006, 2007). Namely, local conditions for
nucleation require a certain degree of local supersaturation
induced by biochemical processes, which can be promoted
by deficiency of inhibitors (like diphosphate, Mg2? or even
citrate ions) and/or the presence of matrix of a bioorganic
material (such as cholesterol) or other crystals of different
solids, those might act as heterogeneous nuclei. In addition,
other regulators (activators and inhibitors) of physiological
biomineralization have been identified and characterized
(Kirsch 2006, 2007; Speer and Giachelli 2004; Giachelli
2005; Giachelli et al. 2005; Schmitt et al. 2006; Azari et al.
2008). What is more, the biological fluids (e.g., serum,
saliva, synovial fluids) are normally supersaturated with
respect to biological apatite precipitation (LeGeros 1991,
2001; Lowenstam and Weiner 1989); therefore, in princi-
ple, calcification is thermodynamically feasible in any part
of the body. However, normally it is not the case. There-
fore, in the healthy body, the appropriate inhibitory
mechanisms must be at work to prevent a superfluous
calcification of soft tissues. These inhibition mechanisms
are a hot research topic in molecular medicine but this
subject is beyond the scope of current review.
In 2010, an arachidic acid Langmuir monolayer system
was reported as a model for pathological mineralization of
ion-substituted carbonate apatites from simulated body
fluid (Dey et al. 2010). The authors demonstrated that the
surface-induced formation of carbonateapatite started from
aggregation of pre-nucleation clusters of yet unknown
CaPO4 leading to nucleation of ACP before further
development of oriented apatite crystals. This process is
schematically shown in Fig. 17 (Co¨lfen 2010; Dey et al.
2010).
To conclude this part, it is worth reminding that CaPO4
of the biological origin are sparingly soluble in aqueous





Biological apatite Enamel, dentine, bone, dental calculi, stones, urinary stones, soft-tissue deposits
OCP Dental calculi and urinary stones
DCPD Dental calculi, crystalluria, chondrocalcinosis, in some carious lesions
b-(Ca,Mg)3(PO4)2 Dental calculi, salivary stones, arthritic cartilage, soft-tissue deposits
Ca2P2O72H2O Pseudo-gout deposits in synovium fluids
ACP Heart calcifications in uremic patients, kidney stones
44 Prog Biomater (2016) 5:9–70
123
solutions. Therefore, removing them from the places of
unwanted deposition would be an equivalent of bone
demineralization; that is a challenge. Thus, the majority of
therapeutic approaches are directed at preventing the pro-
gression of pathological calcifications. Among them, a
chelation therapy might be of some interest to chemists and
materials researchers because it deals with chemical pro-
cesses (Lamas and Ackermann 2000; Knudtson et al.
2002). The general principles of demineralization and
decalcification (i.e., removing the mineral Ca-containing
compounds (phosphates and carbonates) from the bioor-
ganic matrix) have been extensively reviewed (Ehrlich
et al. 2008, 2009), where the interested readers are referred
to.
Biomimetic crystallization of CaPO4
The term ‘‘biomimetics’’ (‘‘the mimicry of life’’) was
coined by an American inventor, engineer and biophysicist
Otto Herbert Schmitt (1913–1998) in the 1950s.
Biomimetics (also known as bionics, biognosis and/or
biomimicry) might be defined as application of the meth-
ods and systems found in nature to the study, design and
construction of new engineering systems, materials,
chemical compounds and modern technology. Another
definition describes biomimetics as a micro-structural
process that mimics or inspires the biological mechanism,
in part or as a whole (Green et al. 2002). This biological
process generates highly ordered materials with a hybrid
composition, a complex texture and ultra-fine crystallites
through a hierarchical self-assembly and begins by
designing and synthesizing molecules that have an ability
to self-assemble or self-organize spontaneously to higher
order structures.
Biomimetism of synthetic materials for biomedical
applications can be carried out at different levels in view of
composition, structure, morphology, bulk and surface
chemical-physical properties. Chemists, biologists, physi-
cists and engineers interested in material science are
amazed by the high degree of sophistication, miniaturiza-
tion, hierarchical organization, hybridizing, reliability,
efficiency, resistance and adaptability characterizing the
natural materials. These properties, which biogenic mate-
rials have achieved through specific building principles
selected by evolution, can be only partially obtained in
manmade materials by present synthetic processes. For this
reason, Nature is a school for material science. Biomi-
metism and bioinspiration represent important tools for the
design and the synthesis of innovative materials and
devices (Roveri et al. 2009b).
Historically, the biomimetic concept is very old (e.g.,
the Chinese wanted to make artificial silk *3000 years
ago; Daedalus’ wings was one of the early design failure),
but the implementation is gathering momentum only in the
20th century. The first papers with the term ‘‘biomimetics’’
in the title were published in 1972 (Burke et al. 1972;
Breslow 1972). In spite of the tremendous achievements of
modern science and technology, the nature’s ability to
assemble inorganic compounds into hard tissues (shells,
spicules, teeth, bones, antlers, skeletons, etc.) is still not
achievable by the synthetic procedures. This is not sur-
prising—designs found in nature are the result of millions
of years of evolution and competition for survival. The
models that failed are fossils; those that survived are the
success (Benyus 1997). In the frames of this review,
Fig. 17 A schematic representation of the different stages of a
surface-directed mineralization of CaPO4. In stage 1, aggregates of
pre-nucleation clusters are in equilibrium with ions in solution. The
clusters approach a surface with chemical functionality. In stage 2,
pre-nucleation clusters aggregate near the surface, with loose
aggregates still in solution. In stage 3, further aggregation causes
densification near the surface. In stage 4, nucleation of spherical
particles of ACP occurs at the surface only. In stage 5, crystallization
occurs in the region of the ACP particles directed by the surface.
Reprinted from Refs. (Co¨lfen 2010; Dey et al. 2010) with permission
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biomimetics is considered as mimicking natural manufac-
turing methods to generate artificial calcified tissues
(grafts, implants, prostheses) those might be used as tem-
porary or permanent replacements of the missing, lost,
injured or damaged bones and teeth. It is important to
notice that precipitation of CaPO4 and calcium carbonates
has been considered to correlate with bone formation, at
least, since 1923 (Watt 1923).
A key step in the biomimetic bone graft production is
attributed to the crystal growth of apatite phase onto a
collagen matrix. Therefore, the matter of choosing the
correct experimental conditions and well-mimicking solu-
tions is of the primary importance. The easiest way to
perform the crystallization would be mixing of aqueous
solutions containing the ions of calcium and orthophos-
phate (LeGeros 1991; Elliott 1994; Amjad 1997). Unfor-
tunately, such type of crystallization provides precipitates
with the properties (chemical composition, Ca/P ratio,
crystallinity level, particle size distribution, etc.) far dif-
ferent from those of biological apatite. This can be
explained by the following paramount differences between
the in vivo biological and in vitro chemical crystallization
conditions (Dorozhkin et al. 2004):
1. In vitro crystallization normally occurs at permanently
depleting concentrations of calcium and orthophos-
phate ions, while the concentrations of all ions and
molecules are kept strictly constant during biological
mineralization (the same is valid for the solution pH);
2. Chemical crystallization is a fast process (time scale of
minutes to days), while the biological process is a slow
one (time scale of weeks to years);
3. Many inorganic, bioorganic, biological and polymeric
compounds are present in biological liquids (blood
plasma, serum, saliva). Each of these compounds
might act as an inhibitor, promoter, nucleator or even
as a template for the growth of biological apatite. In
addition, each of them somehow influences the crys-
tallization kinetics and might be either incorporated
into the solid structure or co-precipitated with CaPO4
(Jahromi et al. 2013).
4. Chemical crystallization is, by all means, a ‘‘passive’’
process, while the biological mineralization is strongly
influenced by cells and occurs by the self-organization
mechanisms (Boskey and Roy 2008; Sato 2006;
Hartgerink et al. 2001). Still there are no good ways
to overcome this difference.
The first and the second differences might be overcome
using the appropriate crystallization techniques. The details
are available elsewhere (Dorozhkin et al. 2004) but, briefly,
the first problem might be overcome by either a continuous
flow of a supersaturated solution (Izquierdo-Barba et al.
2000; Vallet-Regı´ et al. 2000) or using a constant-
composition (CC) technique (Nancollas and Wu 2000;
Koutsoukos et al. 1980; Tomson and Nancollas 1978). The
second difference might be surpassed by a restrained dif-
fusion of calcium and orthophosphate ions from the
opposite directions in, for example, a double-diffusion
(DD) crystallization device or in viscous gels (Busch et al.
1999; Manjubala et al. 2006; Cai et al. 2010; Yokoi et al.
2010; Sadjadi et al. 2010). The CC and DD techniques
have been combined into a single constant-composition
double-diffusion (CCDD) device, which currently seems to
be the most advanced experimental tool to perform bio-
mimetic crystallization (Dorozhkin et al. 2003, 2004;
Dorozhkin and Dorozhkina 2003, 2005; Dorozhkina and
Dorozhkin 2003a; Dorozhkin 2007b). However, in no case,
the CCDD device should be considered as the final con-
struction; it still has much room for further improvement,
e.g., by upgrading the design of the crystallization chamber
(Becker and Epple 2005). Other constructions, e.g., to
study calcification of biological heart valve prostheses
(Krings et al. 2006), are also possible. In addition, one
should keep in mind that the potential of the standard CC
technique has not reached its limit yet: for example, a good
mimicking of the self-organized microstructure of tooth
enamel has been achieved (Wang et al. 2008b).
The third major difference between the in vivo and
in vitro crystallization conditions might be overcome using
the appropriate crystallization solutions (Dorozhkin et al.
2004). To the best of my findings (Dorozhkin 2012a,
2013a), the presence of calcium and orthophosphate ions in
the biological fluids (blood, saliva, lymph, etc.) has been
known since, at least, 1804 (Fourcroy 1804). Therefore, the
best way would be to perform experiments using these
natural liquids, but this is not easy due to both a great
variability of their chemical and biochemical compositions
and problems with their collection and storage. As stated
before, using supersaturated aqueous solutions containing
only the ions of calcium and orthophosphate appears to be
unable to mimic the crystallization of biological apatite;
therefore, more advanced solutions have been elaborated.
According to the topical review on the subject (Tas 2014),
a formulation developed by Tyrode in 1910 (Tyrode 1910)
was the first simulating medium, containing dissolved ions
of calcium and orthophosphate together with other inor-
ganic ions; however, no information was found on appli-
cability of that solution for CaPO4 crystallization.
Therefore, the earliest solution, suitable for CaPO4 crys-
tallization was introduced 1943 by Earle (Earle 1943) and
called Earle’s balanced salt solution (EBSS). EBSS con-
tains inorganic salts (NaCl, KCl, CaCl2, MgSO4, NaHCO3,
NaH2PO4) and was successfully used for CaPO4 crystal-
lization (Termine and Eanes 1974). Other popular physi-
ological solutions comprise Hanks’ balanced salt solution
(HBSS), which contains almost similar inorganic salts and
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glucose (Hanks and Wallace 1949; Shibata et al. 2004;
Marques et al. 2003a; Mareci et al. 2010), Eagle’s mini-
mum essential medium (MEM) and its variation Dul-
becco’s modified Eagle’s medium (DMEM), which contain
numerous bioorganic (alanine, aspartic acid, glycine, bio-
tin, vitamin C, folic acid, riboflavin) and inorganic (CaCl2,
KCl, NaCl, NaH2PO4) components (Meuleman et al. 2006;
Touny et al. 2011; Coelho et al. 2000; Mandel and Tas
2010; Rohanova´ et al. 2014), phosphate-buffered saline
(PBS) that contains only inorganic (CaCl2, MgCl2, KCl,
KH2PO4, NaCl, NaH2PO4) components (Gao et al. 2006;
Lichtenauer et al. 2011). Furthermore, artificial saliva (Sato
et al. 2006; Ionta et al. 2014; Okulus et al. 2014), synthetic
urine (Assimos 2013; Dbira et al. 2015) and simulated milk
ultrafiltrate (SMUF) (Jenness and Koops 1962; Spanos
et al. 2007; Gao et al. 2010a, b) solutions are available.
They contain both bioorganic (e.g., xanthan gum or sodium
carboxymethylcellulose, sorbitol, etc.) and inorganic (e.g.,
CaCl2, MgCl2, KCl, KH2PO4, NaCl, KH2PO4) compounds.
Additional information on the media and physiological
solutions used for mineralization studies is available else-
where (Boskey and Roy 2008; Tas 2014). The majority of
the aforementioned simulating solutions are commercially
available.
However, the most popular biomimetic solution is a
protein-free acellular simulated body fluid (SBF). It was
introduced in 1990 by Kokubo et al., (Kokubo et al. 1990)
and occasionally named as Kokubo’s SBF. It is a
metastable aqueous solution with pH * 7.40, supersatu-
rated with respect to the precipitation of OCP, b-TCP,
CDHA and HA (Lu and Leng 2005), containing only
inorganic ions in concentrations nearly equal to those in
human blood plasma. However, the standard SBF formu-
lation, first, contains the tris/HCl buffer, and, second, the
concentration of hydrogencarbonate (4.2 mM) is only a
fraction of that in blood plasma (27 mM) (Kokubo et al.
1990). The problem of a low concentration of hydrogen-
carbonate ions has been overcome by first introducing a
‘‘synthetic body fluid’’ (Tas 2000; Landi et al. 2005; Jalota
et al. 2008) and later a revised SBF (rSBF) (Kim et al.
2001; Oyane et al. 2003). Due to the chemical similarity
with human blood plasma, rSBF currently seems to be the
best simulating solution. However, it contains Hepes buf-
fer, loses CO2 in open vessels and does not contain any
organic and/or biological molecules (Kim et al. 2001;
Oyane et al. 2003). Other types of SBF are also available
(Mu¨ller and Mu¨ller 2006; Hu et al. 2006; Wen et al. 2009;
Gemelli et al. 2010) and the interested readers are referred
to a leading opinion co-authored by the SBF inventor
(Kokubo and Takadama 2006), where the entire history and
the preparation techniques of various SBF formulations are
well described. Later, another leading opinion on the
suitability of SBF for the in vitro bioactivity tests was
published (Bohner and Lemaitre 2009). The authors
demonstrated that (1) there is presently no enough scien-
tific data to support the SBF suitability and (2) even though
bioactivity tests with SBFs are valid, the way the tests are
generally conducted leaves room for further improvements.
In addition, the preparation protocol of SBF solutions was
reconsidered and a new procedure was suggested to
improve the reproducibility of bioactivity tests (Bohner and
Lemaitre 2009). However, the situation with SBF appears
to be not so straightforward. Namely, further studies
revealed that the actual behavior of osteoblasts was likely
to provide the primary measures of biocompatibility and
bioactivity, rather than oversimplified and essentially
irrelevant tests with SBF (Pan et al. 2010), while the
in vitro bioactivity experiments performed with SBF did
not always predict the relative in vivo performance of the
same implants (Zadpoor 2014).
The application of SBF for the surface mineralization of
various materials in vitro has been reviewed (Kim 2003),
while the theoretical analysis of CaPO4 precipitation (the
driving force and the nucleation rate based on the classical
crystallization theory) in SBF is also available (Lu and
Leng 2005). It is important to note that nanometer-sized
pre-nucleation clusters in SBF solutions have been dis-
covered (Dey et al. 2010); those clusters are believed to be
the initial building blocks of crystallized CaPO4 [e.g.,
CDHA (Onuma and Ito 1998)], while the crystallization
process itself occurs via intermediate formation of ACP
(Fig. 17).
Further attempts to improve the biomimetic properties
of SBF and rSBF have been performed (Kokubo and
Takadama 2006; Bohner and Lemaitre 2009). Efforts were
made to replace artificial buffers (tris/HCl, Hepes) with
simultaneously increasing the concentration of hydrogen-
carbonates for SBF (Marques et al. 2003b, 2004;
Dorozhkina and Dorozhkin 2002b) or avoiding losses of
CO2 from open vessels for rSBF (Dorozhkin et al. 2003,
2004; Dorozhkin and Dorozhkina 2003, 2005; Dorozhkina
and Dorozhkin 2003a; Dorozhkin 2007b) by means of
permanent bubbling of gaseous CO2 through the solutions.
Addition of the most important organic and biological
compounds like glucose (Dorozhkin et al. 2003), albumin
(Dorozhkin and Dorozhkina 2003; Marques et al. 2004),
lactates (Pasinli et al. 2010) and collagen (Sun and Wang
2010) is another direction to improve biomimetic proper-
ties of various types of SBF. Once a cow milk-based rSBF
has been prepared (Dorozhkin and Dorozhkina 2007).
Further improvements of all biomimetic solutions are to be
made in future. Occasionally, condensed solutions of SBF
[e.g., 1.5-fold, twofold (Sun and Wang 2010; Miyaji et al.
1999; Kim et al. 2000b), fivefold (Barrere et al. 2002a, b)
and even tenfold (Tas and Bhaduri 2004; Demirtas¸ et al.
2015)] are used to accelerate precipitation and increase the
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amount of precipitates. However, whenever possible this
should be avoided because the application of condensed
solutions of SBF leads to changes in the chemical com-
position of the precipitates; namely, the concentration of
carbonates increases, while the concentration of
orthophosphates decreases (Dorozhkina and Dorozhkin
2003b).
To conclude this part, one should note on the diffi-
culties in mimicking the calcification process that occurs
in bones and teeth. A reasonable mechanism of the
induction of CDHA nucleation and crystallization by
carboxylate groups on the bioorganic matrices looks as
this. At first, calcium and orthophosphate ions are com-
bined with carboxylate groups. By using this as seeds,
CDHA crystals then grow to generate interfaces that
contain the most stable structure of the {100} faces. Such
a crystallization mechanism explains why the c-axes of
biological apatite are parallel to the organic matrices.
Collagen fibers can be regarded as axis-like organic
matrices: when CDHA is formed on the surface of col-
lagen fibers parallel to the c-axes, the c-axes are oriented
parallel to the fiber orientation (Sato 2007). A step further
would be to perform the precipitation from the simulating
solutions on templates of biomineralization proteins for
the control of crystal organization and properties. For
example, there are successful attempts to crystallize
CaPO4 on collagen to obtain bone-like composites (Nassif
et al. 2010; Li et al. 2011; Xia et al. 2012, 2013, 2014;
Antebi et al. 2013). Such collagen/CaPO4 biocomposites
are currently under investigation for clinical use. Other
popular matrixes to perform biomimetic CaPO4 crystal-
lization comprise gelatin (Busch et al. 1999; Rosseeva
et al. 2008; Liu et al. 2009; Raz et al. 2014), chitosan
(Raz et al. 2014; Wang et al. 2011; Lu et al. 2014b), the
surface of metals and alloys (Wang et al. 2004; Bigi et al.
2005; Liu et al. 2010, 2013; Dorozhkin 2014), polymers
(Iwatsubo et al. 2006), cellulose (Bodin et al. 2006), self-
assembled monolayers (Toworfe et al. 2006) and many
other materials. Such biomimetically prepared CaPO4
precipitates are occasionally called ‘‘organoapatites’’
(Spoerke and Stupp 2003; Storrie and Stupp 2005).
Conclusions and outlook
By the end of the XX-th century, it became clear that
CaPO4-based biomaterials and bioceramics by themselves
could not give a complete response to the clinical needs for
artificial implants. Biomaterials with more demanding
properties were required. Namely, in 1998, Prof. Larry L.
Hench published a forecast for the future of biomaterials
development (Hench 1998), where he noted that available
that time bioactive materials (CaPO4, bioactive glasses and
glass ceramics) had already improved prostheses lifetime
but, unfortunately, any type of prosthesis had mechanical
limitations. As the solution, he proposed that biomaterial
researchers would need to focus on tissue regeneration
instead of tissue replacement. A working hypothesis was
announced: ‘‘Long-term survivability of prosthesis will be
increased by the use of biomaterials that enhance the
regeneration of natural tissues’’ (Hench 1998). One path to
follow is the regeneration of bone using CaPO4-based
scaffolds that mimic the structure of biological apatite,
bond to bone and in some cases activate the genes within
bone cells to stimulate new bone growth (Jones and Hench
2003; Griffith and Naughton 2002; Hench and Polak 2002).
Thus, in 2002, Hench predicted a rapid development of
tissue engineering field, where CaPO4 play an auxiliary
role. The practice reveals that tissue engineering, indeed, is
a very rapidly developed field of science and research
(Ratner and Bryant 2004).
However, what can be said about CaPO4 themselves?
The major questions on chemistry, crystallization, ion-
substitution, crystallography, thermodynamics and phase
relationships for the chemically pure CaPO4 have been
answered in the XXth century. Some important topics for
DCPD and CDHA have been additionally investigated in
the field of self-setting CaPO4 formulations (Dorozhkin
2013b). Conversely, CaPO4 of biological origin, including
the control of their morphology and interaction of CaPO4-
based bioceramics with various bioorganic compounds are
not well investigated yet. The same is valid for the
nanocrystalline and amorphous samples of CaPO4. Small
amounts of bone-like apatite might be easily prepared by
crystallization from simulating solutions, such as SBF and
rSBF, but what can be said about larger quantities? A
standard way of the concentration increasing causes
chemical changes in the precipitates (Dorozhkina and
Dorozhkin 2003b). After a necessary technology is devel-
oped, one will have to think on scaffold preparation from
this material, keeping in mind that any thermal treatment
would destroy this material. A spark plasma sintering
approach based on the use of pulsed current and enabling
very fast heating and cooling rates seemed to be a first hint
to achieve this goal (Zhang et al. 2008; Grossin et al.
2010). However, a rapid development of the self-setting
CaPO4 formulations, which can be easily doped by the
necessary chemical elements, seems to be a better solution
of this problem (Dorozhkin 2013b). Furthermore, the
existence of OA remains to be questionable, as well as the
bioactivity mechanism of CaPO4 requires better
understanding.
To date, although CaPO4-based biomaterials and bio-
ceramics have been extensively studied for over 50 years,
their ability to trigger bone formation is still incomparable
with other biomaterials. Nowadays, the biomaterials’ field
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is shifting towards biologically active systems to improve
their performance and to expand their use (Kolk et al.
2012; Garg and Goyal 2014; Tang and Diehl 2014).
Therefore, tissue engineering is the strongest direction of
current research, which, in the case of CaPO4, means
fabrication of proper substrates and/or scaffolds to carry
cells, hormones and biochemical factors to be further used
in surgery and medicine (Zhou and Lee 2011; Zakaria et al.
2013; Shao et al. 2015). Presumably, a synthesis of various
types of CaPO4-based biocomposites and hybrid biomate-
rials occupies the second important place (Dorozhkin
2015b). The third important place is occupied by investi-
gations devoted to the synthesis and characterization of
various nano-sized particles and nanodimensional crystals
of CaPO4 (Dorozhkin 2013d), ACP (Dorozhkin 2012c), as
well as CaPO4 with controlled particle geometry and
shapes (Lin et al. 2014; Galea et al. 2013; Kalia et al.
2014). In general, the geometry of crystal phases can be
varied by controlling the precipitation conditions, such as
temperature, solution pH, concentration of the reagents,
hydrodynamics, presence of various admixtures, inhibitors
or promoters and ultrasonication. All these approaches
might be useful in preparation of CaPO4 fibers, whiskers,
hollow microspheres, etc. In addition, a great attention is
paid to manufacturing of the self-setting CaPO4 formula-
tions (Dorozhkin 2013b) and multiphase formulations
(Dorozhkin 2012d) mimicking as closely as possible the
mineral component of biological apatite. A work along the
ecological ways of synthesis of CaPO4 might be of a great
importance as well (Dorozhkin 2008). A deeper study of
the fascinating growth rate of deer antlers and the ability of
some animals, such as newts, to regenerate amputated
limbs might provide new and unexpected approaches to the
bone-healing concept, as well as this will be important for
further development of both biomimetics and biomineral-
ization fields. Unfortunately, no currently available graft-
ing biomaterials can substitute the bones’ mechanical
function, illustrating yet unmet medical need that would
entirely substitute and regenerate a damaged tissue or
organ. In a close future, the foreseeable application of
CaPO4 will be as an integrated component of the third
generation of biomaterials (Hench 1998; Hench and Polak
2002), where they will support cells and/or other biologi-
cally active substances (peptides, growth factors, hor-
mones, drugs, etc.) to guide regeneration of hard tissues
(Daculsi et al. 2013; Feng et al. 2013b; Miura et al. 2013;
Wang et al. 2014c).
To finalize this review, one should note that in spite of
almost the 250-year long history of the CaPO4 research
(Dorozhkin 2012a, 2013a) and many important discoveries,
still many gaps remain in our knowledge to be investigated
in future.
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